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Summary 
A major task of the immune system is to identify cells that have been infected by a virus or that 
have mutated, and discriminate them from healthy cells. This duty is assigned to cytotoxic T-
lymphocytes (CTL), which scan epitopes presented to them on cell surfaces derived from 
intracellular proteins through the MHC-I antigen processing pathway. The goal of this work is to 
provide computational methods that allow to predict which epitopes get presented from the large 
pool of peptide candidates contained in intracellular proteins. This is achieved by examining the 
selective influence of three major steps in the pathway: peptide generation by the proteasome, 
peptide transport into the ER by TAP, and binding of peptides to MHC-I molecules. 
For peptide binding to MHC-I, a new algorithm is developed that combines a matrix-based 
method describing the contribution of individual residues to binding with pair coefficients 
describing pair-wise interactions between positions in a peptide. This approach outperforms 
several previously published prediction methods, and for the first time quantifies the impact of 
interactions in a peptide. The distribution of the pair coefficient values shows that interactions 
are not limited to amino acids in direct contact, but can also play a role over longer distances. 
Compared to the matrix entries, the pair-coefficients are rather small, explaining why methods 
completely ignoring interactions can nevertheless make good predictions. 
Next, a novel algorithm is developed to predict the TAP affinities of peptides of any length. 
Longer peptides are important because several MHC-I epitopes are generated by N-terminal 
trimming of precursor peptides transported into the ER by TAP. As the true in vivo precursors of 
an epitope are not known, a generalized TAP score is established which averages across the 
scores of all precursors up to a certain length. The ability of this TAP score to discriminate 
between epitopes and random peptides shows that the influence of TAP is a consistent, strong 
pressure on the selection of MHC-I epitopes.  
Using predicted TAP transport efficiencies as a filter prior to the prediction of MHC-I binding 
affinities, it is possible to further improve the already very high classification accuracy achieved 
using MHC-I affinity predictions alone. Such a 2-step prediction protocol failed when 
predictions of C-terminal proteasomal cleavages were combined with MHC-I affinity 
predictions. This disappointing result is thought to be caused by the lack of a sufficiently large 
set of quantitative and consistent experimental data on proteasomal cleavage rates, which are 
more difficult to measure and interpret than the affinity assays used to characterize peptide 
binding to TAP and MHC-I. Therefore, a new protocol for the evaluation of proteasomal digests 
is developed, which is applied to a series of experiments. This novel protocol addresses two 
problems: (1) Using mass-balance equations, a method is developed to quantify peptide amounts 
from MS-signals. (2) By introducing the first kinetic model of the 20S proteasome capable of 
providing a satisfactory quantitative description of the whole time course of product formation, 
cleavage probabilities can be extracted reliably from proteasomal in vitro digests. 
Keywords: Prediction, Antigen Processing, MHC, TAP, Proteasome. 
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Zusammenfassung 
Das Immunsystems muss gesunde Zellen von infizierten und Krebszellen unterscheiden können, 
um letztere selektiv zu bekämpfen. Dies ist die Aufgabe der CTL-Zellen, die dazu auf der 
Zelloberfläche präsentierte Peptide die aus intrazellulären Proteinen der jeweiligen Zelle 
stammen untersuchen. Diese präsentierten Peptide (Epitope) werden durch den MHC-I 
Antigenpräsentationsweg hergestellt. Das Ziel dieser Arbeit ist es Methoden zu entwickeln die 
Epitope aus der großen Zahl prinzipiell in Proteinen enthaltener Peptide heraussuchen können. 
Dazu wird die Selektivität dreier wichtiger Komponenten des Präsentationsweges untersucht: 
Die Herstellung der Peptide durch das Proteasom, der Transport in das ER durch TAP, und das 
Binden von Peptiden an leere MHC-I Moleküle.  
Zur sequenzbasierten Vorhersage der Bindung von Peptiden an MHC-I Moleküle wurde ein 
neuer Algorithmus entwickelt. Dieser kombiniert eine Matrix, welche die individuellen Beiträge 
einzelner Reste zur Bindung beschreibt, mit Paarkoeffizienten, die Wechselwirkungen zwischen 
verschiedenen Positionen im Peptid beschreiben. Dieser Ansatz macht bessere Vorhersagen als 
bisher publizierte Methoden, und quantifiziert erstmals den Einfluss von Wechselwirkungen 
innerhalb eines Peptids auf die Bindung. Die Verteilung der Werte der Paarkoeffizienten zeigt, 
dass sich Wechselwirkungen nicht auf benachbarte Aminosäuren beschränken. Im Vergleich zu 
den Matrixeinträgen sind die Werte der Paarkoeffizienten klein, was erklärt warum Vorhersagen 
die Wechselwirkungen komplett vernachlässigen trotzdem gut sein können. 
Erstmals wurde ein Algorithmus zur Vorhersage der TAP-Transportseffizienz von Peptiden 
beliebiger Länge entwickelt. Das ist deshalb wichtig, da viele MHC-I Epitope als N-terminal 
verlängerte Prekursoren in das ER transportiert werden. Für die Vorhersage der 
Transportfähigkeit eines potentiellen Epitopes wird deshalb über die Transporteffiziens des 
Epitopes selbst und seiner Prekursoren gemittelt. Mit Hilfe dieser Definition von 
Transportfähigkeit wird gezeigt, dass TAP einen starken selektiven Einfluss auf die Auswahl von 
MHC-I Epitopen hat.  
Indem man Peptide die als 'nicht-transportierbar' vorhergesagt werden als mögliche Epitope 
ausschließt, kann man die ohnehin schon hohe Qualität von MHC-I Bindungsvorhersagen weiter 
steigern. So eine zweistufige Vorhersage scheitert, wenn man statt des TAP Transports die 
Vorhersage der Generierbarkeit eines Epitopes durch das Proteasom als Filter verwenden 
möchte. Dieses schlechte Abschneiden der proteasomalen Schnittvorhersagen wird auf eine 
mangelhafte experimentelle Datenbasis zurückgeführt, da proteasomale Schnittraten schwieriger 
zu messen und interpretieren sind als die Affinitätsdaten für TAP und MHC-I. Um die 
experimentelle Datenbasis in Zukunft verbessern zu können, wurde ein neues experimentelles 
Protokoll entwickelt und an einer Reihe von Experimenten getestet. Dabei werden zwei 
Probleme behandelt: (1) Durch die Verwendung von Massenbilanzen werden MS-Signale in 
quantifizierte Peptidmengen umgerechnet. (2) Durch das erste kinetische Modell des 
Proteasomes das die Entstehung und den Abbau von Peptiden während eines Verdaus zufrieden 
stellend beschreiben kann, können aus den Verdaudaten Schnittraten bestimmt werden. 
Schlagworte: Vorhersage, Antigen Prozessierung, MHC, TAP, Proteasom. 
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1 Introduction - the MHC-I pathway 
A major task of the immune system is to identify cells that have been infected by a virus or that 
have mutated, and discriminate them from healthy cells. This duty is assigned to cytotoxic T-
lymphocytes (CTL cells)1. Since it is not possible to examine the entire contents of a cell without 
destroying it, the CTL cells rely on the inspected cells to exhibit a representative fraction of their 
content on the surface. This is realized by the MHC-I antigen procession and presentation 
pathway (Figure 1) which consists of the following steps: In the cytosol, proteins are degraded 
by the proteasome, some of them at the end of their useful lifetime, some of them (about 40%) 
directly after synthesis. Most of the peptide fragments generated by the proteasome are further 
degraded by other cytosolic proteases into single amino acids used for the synthesis of new 
proteins. Some of the peptides escape degradation and are transported into the endoplasmic 
reticulum (ER) by the membrane spanning transporter TAP. There the peptides can again be 
degraded by the recently identified aminopeptidase ERA(A)AP (Saric, et al., 2002; Serwold, et 
al., 2002; York, et al., 2002) or exported back into the cytosol, unless they are able to bind to an 
empty MHC-I molecule. Once a peptide binds, the MHC-I - peptide complex is transported to 
the cell surface, where it is presented to CTL cells. The presented peptides are called T-cell 
epitopes.  
                                                 
1 If not explicitly cited otherwise, the information in this chapter is taken from three recent 
reviews: Kloetzel, P. M. (2001): Antigen processing by the proteasome, Nat Rev Mol Cell Biol 2 
[3], pp. 179-87, Lankat-Buttgereit, B. and Tampe, R. (2002): The transporter associated with 
antigen processing: function and implications in human diseases, Physiol Rev 82 [1], pp. 187-
204. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list
_uids=11773612, Shastri, N.; Schwab, S. and Serwold, T. (2002): Producing nature's gene-chips: 
the generation of peptides for display by MHC class I molecules, Annu Rev Immunol 20, pp. 
463-93. 
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 Figure 1: Schematic overview of the MHC-I antigen processing and presentation pathway 
The CTL cells can discriminate between epitopes that are 'normally' presented to them, and those 
that are not. The definition of what is normal is made during development of the thymus: Of a 
large initial population of CTL cells, those reacting on any of the epitopes presented to them at 
this stage are deleted. Later in life, when detecting a foreign epitope, a CTL cell kills the 
inspected cell and secretes γ-interferon, which causes changes in the antigen procession of 
neighboring cells, some of which are described below.  
The goal of this work is to provide computational methods that allow predicting which peptides 
from the large pool of candidates that in principle can be derived from intracellular proteins are 
presented as T-cell epitopes. Such prediction tools would be useful for several immunological 
applications including the intelligent design of peptide vaccines, i.e. predicting an epitope 
contained in a viral protein sequence which would be presented by cells infected with that virus, 
designing a vaccine containing this epitope in a less harmful context, and using this vaccine to 
train the immune system to illicit a strong response when encountering this epitope.  
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The approach to such a prediction taken in this work is to define the selective influences of three 
main agents in the pathway: Peptide generation by the proteasome (chapter 4), transport into the 
ER by TAP (chapter 3) and binding to MHC-I (chapter 2). Each of these steps is examined 
individually, resulting in algorithms that are able to predict the efficiency of each step for a given 
substrate. Combining the individual predictions leads to a model describing epitope selection of 
the entire pathway. While this is shown to work for TAP and MHC-I, predictions of proteasomal 
cleavage give inferior results, which is assumed to be the consequence of lesser quality 
experimental data. Therefore new ways of gathering and interpreting such data are introduced in 
chapter 4.  
1.1 Structure and function of the main pathway components 
In this section, an overview of the structure and biological function of the three main 
components of the MHC-1 pathway is given, which are examined in the rest of this work. 
Readers solely interested in the development of mathematical prediction algorithms can proceed 
directly to chapter 2. 
1.1.1 The proteasome generates peptides by degrading proteins 
Proteasomes are self-compartmentalizing multi-subunit protease complexes performing most of 
the non-lysosomal proteolysis in eukaryotic cells. All proteasomes isolated from eukaryotic cells 
until now contain the so-called 20S proteasome as the catalytic core. In Figure 2, the crystal 
structure of the 20S proteasome in yeast is shown. It depicts a cylindrical particle consisting of 
28 subunits arranged in four heptameric rings. The two inner ß-rings form the central cavity of 
the cylinder and harbor at their inner surface the proteolytic active sites. In eukaryotic 20S 
proteasomes, only three ß subunits (ß1, ß2 and ß5) are active, with an N-terminal threonine as 
the catalytic residue. Each of these subunits has a distinct substrate preference, which is usually 
characterized by the rate in which it cleaves small fluorogenic peptides. Intriguingly, stimulation 
of cells by γ-interferon causes the replacement of the three active ß-subunits ß1, ß2 and ß5 by 
their iso-forms ß1i, ß2i and ß5i in newly synthesized proteasomes. Because these subunits are 
induced by γ-interferon, signaling an infection in the vicinity of the cell, it is assumed that these 
new 'immuno-proteasomes' enhance the antigen procession capability of a cell. The immuno-
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subunits do posses a distinct cleavage preference, but it is not exactly clear how this improves 
antigen processing. 
side view front view
α       β       β       α
 
Figure 2: Structure of the 20S yeast proteasome published by (Groll, et al., 1997). 
The α-subunits of the two outer rings form the boundary of a gated channel through which the 
traffic of incoming substrates and outgoing peptides is likely to proceed (Groll, et al., 2000; 
Kohler, et al., 2001). In vivo, the 20S core proteasome is usually found associated with 19S and / 
or 11S regulatory complexes. These regulators dock at the α rings and are believed to control the 
access to the core channel. The 19S regulators recognize proteins tagged with a poly-ubiquitin 
chain, which marks them for degradation. The 11S regulators are induced by γ-interferon which 
again makes it likely that their function enhances the antigen procession capability of a cell. In 
contrast to the 20S core alone, these 26S proteasomes need ATP to function.  
Proteasomes are essential to life. Chromosomal deletions of each of the 14 yeast 20S proteasome 
genes are lethal (Heinemeyer, et al., 1991; Hilt and Wolf, 1995). Functional integrity of 
proteasomes has been demonstrated to be indispensable for a variety of cellular functions besides 
generation of antigenic peptides such as metabolic adaptation, cell differentiation, cell-cycle 
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control, stress response and removal of abnormal proteins (Hilt and Wolf, 1996). The role as 
supplier of antigenic peptides was presumably taken over by the proteasome during the evolution 
of the immune system because of its ancient property to cleave substrates into smaller peptides 
(Niedermann, et al., 1997).  
Originally it was thought that peptides generated by the proteasome during normal protein turn-
over would be the only source of fragments for the MHC-I pathway. However it has been known 
for some time that around 40% of proteins are degraded by the proteasome within a minute of 
synthesis, which is thought to be a consequence of their inability to fold. Degradation of these 
defective ribosomal proteins (DRiPs) has been found to be a main source of antigenic peptides 
(Schubert, et al., 2000). This gives the immune system access to all proteins at the point of 
synthesis, independent of their lifetime and final location in the cell.  
Apart from the proteasome, several other proteases have been implicated in the generation of 
antigenic peptides. Among these are the tripeptidyl peptidase II, furin and the thimet 
oligopeptidase. (Schwarz, et al., 2000). Their importance is not yet completely clear, but it can 
be assumed that because of their selective specificity, they can only play a role in the generation 
of a minority of observed antigenic peptides.  
1.1.2 TAP transports peptides into the ER 
TAP is a heterodimer consisting of TAP1 and TAP2, each of which contains transmembrane 
domains and an ATP binding motif. No crystal structure of TAP is currently available, but it is 
known from sequence homology analysis that TAP belongs to the super family of ATP-binding 
cassette transporters (ABC transporters). The TAP genes are coded in the MHC-II locus, and are 
up regulated after stimulation with γ-interferon (Ayalon, et al., 1998), which implicates the role 
of TAP in antigen procession.  
The initial selective step of TAP transport is binding of the peptide, which involves both subunits 
of TAP. This is followed by a slow structural reorganization of the molecule, which is believed 
to trigger ATP hydrolysis and peptide translocation across the membrane (Neumann and Tampe, 
1999). TAP specificity has been analyzed using combinatorial peptide libraries (Uebel, et al., 
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1995) showing that the C-terminus and the three N-terminal residues of a peptide contribute 
most to binding to TAP. The optimal lengths of peptides for transport is 8-16 amino acids, but 
oligopeptides up to 40 residues in length have been shown to be transported (Momburg, et al., 
1994; van Endert, et al., 1994).  
 
Figure 3: Epitope (blue) in the binding groove of the MHC-I α-chain (orange). Structure 
published by (Khan, et al., 2000). 
1.1.3 MHC-I molecules present bound peptides on the cell surface  
Loaded MHC-I molecules are heterotrimers consisting of the presented epitope bound to the 
polymorphic α-chain which is again bound to the invariant β2 microglobulin. Figure 3 depicts a 
peptide in the binding pocket of the MHC-I molecule. Polymorphism in the α chain primarily 
involves residues in the binding pocket, giving rise to the large variety of binding specificities 
observed for different MHC-I alleles. Each human has up to six different MHC-I alleles, out of 
980 different ones currently known (February 2003, www3.ebi.ac.uk/Services/imgt/hla/cgi-
bin/statistics.cgi).  
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The assembled empty MHC-I molecules are associated with TAP, and the molecule tapasin acts 
as a bridge between the two. This places the empty MHC-I molecules close to the peptide source 
and retains them there until they are loaded with a peptide. The loaded MHC-I molecules leave 
the ER via the Golgi apparatus and the trans-Golgi network to the cell surface. Several hundred 
thousand copies of MHC-I molecules each containing a single epitope are presented at any time 
on the cell surface, where their epitopes are scanned by CTL cell receptors as shown in Figure 4.  
 
MHC-molecule
T-cell receptor
presented 
epitope
 
Figure 4: MHC-I bound epitope is scanned by T-cell receptor. Structure published in 
(Garboczi, et al., 1996). 
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2 Peptide binding to MHC-I 
Binding to MHC-I is the most selective requirement for a peptide to become an epitope through 
the MHC-I pathway. This has directed most experimental and theoretical work aimed at MHC-I 
epitope prediction towards this step. In this chapter a new method to predict the affinity of a 
peptide to an MHC-I molecule is introduced and compared to existing prediction methods. 
Special interest is paid to the independent binding assumption, which states that each residue 
within a peptide contributes independently to the overall binding of the peptide. Several 
published prediction methods make this assumption, while others claim it to be invalid because it 
neglects interactions between peptide positions. Here, for the first time the violation of the 
independent binding assumption is quantified.  
This chapter is organized as follows: The first section (2.1) gives an overview of existing 
prediction algorithms, followed by a description of the available datasets consisting of peptides 
with measured affinities, which are needed for training and testing of the algorithms (section 
2.2). Section 2.3 explains how predictions from existing algorithms were obtained. This is 
followed by the introduction of the novel SMM prediction method (section 2.4), and a 
description of the means to compare the prediction quality of different methods (section 2.5). In 
section 2.6, all algorithms making the independent binding assumption are compared, including 
the novel SMM method. This is followed by a comparison of general prediction methods not 
making that assumption in section 2.7. In section 2.8, the SMM prediction method is extended to 
include pair coefficients describing the pair-wise interactions between peptide positions, thus 
dropping the independent binding assumption. Finally, the distribution of these quantified pair-
wise interactions between peptide positions is analyzed (section 2.9). 
Most of the results presented in this chapter are taken from (Peters, et al., 2003). 
2.1 Overview of existing prediction methods  
When the first peptides binding to MHC-I molecules were sequenced (Rotzschke, et al., 1990), it 
soon became clear that each MHC-I molecule has its own narrow binding preference. Only 
peptides of a certain length were found, typically 8-10 amino acids long. Some positions in the 
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binding peptides called anchor positions could only be occupied by a few different amino acids. 
Apparently, peptides interact more strongly with the MHC-I molecule at these anchor positions, 
limiting the number of amino acids tolerated there. Using pool sequencing of peptides eluted 
from one type of MHC-I allele (Falk, et al., 1991), it could be characterized which amino acids 
are allowed at the anchor positions. Demanding compliance with this anchor motif was the first 
method to predict which peptides are potential MHC-I binders (Rotzschke, et al., 1991).  
With more data available, it became apparent that there are several peptides binding to MHC-I 
that do not comply with the anchor motif or, more often, that peptides containing the motif did 
not bind (Jameson and Bevan, 1992). This lead to extensions of the motif method, listing more 
and more good, bad or tolerated residues for binding at the different peptide positions. One 
deficiency of such a listing is that it does not say if a good residue at one position can 
compensate for a bad residue somewhere else. To achieve this, scores were assigned to each 
amino acid at each position. These can be summed up for a given peptide and the total score 
predicts if the peptide is likely to bind or not. This is called a matrix based prediction, because 
the scores for each peptide position and amino acid can be written in the form of a matrix like the 
one shown in Table 1.  
2.1.1 Matrix prediction methods: BIMAS, SYFPEITHI and PM 
The first scoring matrix for MHC-I binding was introduced by (Parker, et al., 1994), which is in 
the following called the BIMAS method. The experimental basis was a set of peptides with 
measured half-life dissociation constants for the HLA-A0201 allele. The matrix coefficients 
were determined mathematically by minimizing the distance between predicted matrix scores for 
the peptides and the logarithms of their measured half-life constants. This makes the matrix score 
a prediction of a peptides half-life of dissociation, and therefore of its strength of binding.  
A major contribution to the prediction of epitopes was the establishment of the SYFPEITHI 
database (Rammensee, et al., 1999; Rammensee, et al., 1995). This database is a collection of 
sequences of naturally processed epitopes and peptides known to bind to MHC-I molecules, 
which serves as the basis for a scoring algorithm. To determine a scoring matrix for a given 
allele, the frequencies of amino acids in peptides binding to that allele are used to manually 
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determine scores for each peptide position. There is no experimental interpretation of the 
SYFPEITHI score, it simply reflects the agreement of a peptides sequence with that of 
previously known binders and epitopes. As the sequences of naturally processed epitopes also 
reflect the selectivity of other components in the antigen procession pathway, these matrices do 
not describe the pure binding specificity of an MHC-I allele, but it is assumed that the influence 
of other pathway agents is small compared to the selectivity of MHC-I binding. 
Another matrix based prediction approach is called the polynomial method (PM) (Gulukota, et 
al., 1997). It has the advantage of being very easy to calculate from a set of peptides with known 
affinity values. Each matrix entry corresponding to a particular amino acid type at a particular 
peptide position is calculated as the mean affinity of all peptides containing that amino acid type 
at that position.  
2.1.2 The independent binding assumption 
A matrix based prediction necessarily assumes, that the contribution to binding of each residue in 
a peptide is independent of the other residues in the peptide. This is a daring assumption, known 
to be false for many other biological problems. However, matrix based algorithms work 
surprisingly well for MHC-I affinity predictions: Scoring matrices are usually calculated with 
little experimental data (typically hundreds of peptides) compared to the size of sequence space 
(for 9-mers: 209), and still give good predictions. This shows that the relationship between 
sequence and affinity can at least roughly be approximated by the independent binding 
assumption. The assumption is also supported by structural data showing that peptides bind in an 
extended conformation in the MHC-I groove, so that contacts between residues of the bound 
peptide are limited. 
2.1.3 General prediction methods: ANN, CART and the additive method 
Even if independent binding is a justified approximation, a method without this restriction 
should be able to make better predictions if interactions between peptide positions play a role at 
all. In the following, such methods are called general methods, in contrast to those making the 
independent binding assumption. The first general methods used to predict binding to MHC-I 
were artificial neural networks (ANN) (Gulukota, et al., 1997; Milik, et al., 1998). ANNS are a 
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biologically motivated approach to machine learning. An ANN consists of several layers of 
interconnected ‘neurons’, each of which transfers its input into an output according to some 
mathematical function. The free parameters of this function are determined by learning from a 
set of data where the correct output belonging to an input is known (see (Agatonovic-Kustrin and 
Beresford, 2000) for a review of ANN applications in biomedical sciences). 
Another general prediction method are Classification and Regression Trees (CART). These are 
described in detail in (Breiman, et al., 1984), and were first used by (Segal, et al., 2001) to 
predict MHC-I binding. Briefly, a classification tree is built by introducing splits in a set of 
peptides with known binding capability according to what amino acid is at a certain position of a 
peptide. The splitting is repeated, leading to a tree shaped classification scheme (e.g. Figure 8). 
Each split is chosen so that it maximizes the homogeneity of the peptides in both daughter nodes. 
A perfectly homogenous node contains only binders or only non-binders. A very large tree is 
built first so that all nodes are perfectly homogenous. It is then pruned back to an optimal size 
determined by cross-validation. Each terminal node in the optimal tree is assigned a binding 
score, computed as the percentage of non-binders the node contains.  
The third general prediction method used in this chapter is the additive method (Doytchinova, et 
al., 2002). It consists of a scoring matrix + coefficients describing pair-wise interactions between 
amino acids. The sore of a peptide is calculated by adding those coefficients belonging to pairs 
of amino acids present in that peptide to its matrix score, as described below in equation (6). All 
interactions between neighboring and next-neighbor amino acids are considered. The matrix- and 
interaction coefficients are determined by a partial least square fit to a set of peptides with 
known affinities.  
The prediction methods used in this chapter were chosen because they were freely accessible or 
reasonably easy to reproduce. Other classes of prediction methods based on binding data which 
are not treated here are Hidden Markov Models (Mamitsuka, 1998) and Support Vector 
Machines (Donnes and Elofsson, 2002). There are also prediction methods based on structural 
data of solved peptide-MHC-I complexes. These use threading or molecular modeling 
techniques to identify potential binders (Altuvia, et al., 1995; Schueler-Furman, et al., 2000).  
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2.2 Experimental datasets 
Four non-overlapping sets of 9-mer peptides with known affinities to the HLA-A0201 allele are 
used in this chapter. All datasets are separated into 'binders' and 'non-binders'. The cutoff for 
making this separation is not critical as long as all the binders have a higher affinity than any of 
the non-binders. All sets have similar sequence composition: at the anchor positions 2 and 9, 
amino acids A, I, L, M, T and V are over-represented; at other positions, all 20 amino acids are 
roughly equally represented. For the SYFPEITHI-set, this reflects the occurrence of amino acids 
at these positions in naturally processed epitopes. For the in vitro datasets, where the choice of 
peptides is made by an experimentalist, this bias is also found because experimentalists want to 
include as many binders in their datasets as possible. While it would be better - from a 
mathematical viewpoint - to have binding information of randomly selected peptides, this would 
require far more measurements as only very few random peptides bind. As the described bias is 
present in all learning and test sets, no particular prediction method is favored.  
Train-set: This set consists of 533 peptides with IC50 values measuring their binding affinity to 
the HLA-A0201 molecule, as described in (Gulukota, et al., 1997). IC50 values are measured in 
an assay in which both the peptide of interest and a reference peptide compete for binding to 
HLA-A0201. The IC50 value of a peptide is the concentration at which it has suppressed 50% of 
the reference peptides from binding to MHC-I. The logarithm of the IC50 value can be 
interpreted as the difference in binding free energy between a peptide and the reference. 
Several peptides in the dataset are ‘heavy non binders’, i.e. their IC50 value is too large to be 
measured. Using an IC50 cutoff of 500 nM, the Train-set is split into 127 binders and 406 non-
binders, which of course include the 'heavy non binders'. The cutoff lies within the intermediate- 
to low affinity range; peptides in this set with IC50<50nM are considered to be high-affinity 
binders.  
Blind-set: This set 173 of peptides with IC50 values was measured with the same experimental 
setup as the Train-set. Using the IC50 cutoff of 500 nM, the set is split in 67 binders and 108 
non-binders.  
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BIMAS-set: This set of peptides was published by (Parker, et al., 1994). For 134 peptides, β2 
microglobulin dissociation half-lives have been measured. Four of the peptides overlap with the 
Train-set. By interpolating between their known IC50 and half-life values, the IC50=500nM 
cutoff in the Train-set is translated to a half-life cutoff of approximately 650 minutes. Using this 
cutoff and excluding the overlapping peptides, the BIMAS-set has 25 binders and 105 non-
binders. 
SYFPEITHI-set: 143 peptides binding to HLA-A0201 were taken from the SYFPEITHI 
database, most of which are naturally processed epitopes. All of these were classified as binders, 
even though there is no measured affinity available for them. To have non-binders in this set that 
definitely have lower affinities than these binders, the 59 heavy non-binders from the Blind-set 
were included.  
2.3 Obtaining predictions from published methods 
The BIMAS and SYFPEITHI predictions were obtained from web servers (BIMAS: 
http://bimas.dcrt.nih.gov/molbio/hla_bind/, SYFPEITHI: http://www.uni-tuebingen.de/uni/kxi). 
The training data of these methods contained the equally named test sets described above.  
The PM, CART and ANN predictions were trained using the Train-set described above. For the 
CART method, two commercial software packages (SPSS and CART) were used, leading to an 
identical optimal classification tree shown in Figure 8. Switching from a classification tree used 
here, which needs binary experimental binding data for training, to a regression tree, which uses 
quantitative IC50 values, improves the prediction performance only slightly.  
The ANN was designed as described in (Gulukota, et al., 1997): A feed-forward neural network 
with three layers was built consisting of an input layer with 180 neurons, a hidden layer with 50 
neurons and an output layer with one neuron. The Aspirin/MIGRAINES software package from 
the MITRE Corporation (http://www.emsl.pnl.gov:2080) was used to simulate the network.  
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For the Additive Method, the coefficient values determined in (Doytchinova, et al., 2002) were 
used. The training data used in that paper to determine the coefficient values was a subset of the 
Train-set described above. 
2.4 Introducing the stabilized matrix method (SMM) 
Scoring matrices quantify the contributions of individual residues in a peptide to binding. The 
matrix element si,a corresponds to amino acid a at position i of the peptide. The total score Sk for 
a given peptide k with the amino acids ak(i) at positions i is then given by the summation:  
( )0 ,= + ∑ kk i a i
i
S s s
          (1) 
where s0 is a constant offset.  
In this section, the novel stabilized matrix method (SMM) is developed. It determines the values 
for si,a and s0 by minimizing the distance between predicted scores Sk and measured affinities for 
the peptides in the Train-set:  
{ }( ), measuredi a k k
k
s SΦ = −∑
        (2) 
For a peptide with a measurable IC50 value, the norm in equation (2) has the form:  
( )( )2measured ln IC50k k k kS S− = −        (3) 
Several peptides in the Train-set have too low affinities to measure an IC50 value. For these 
‘heavy non-binders’, the IC50 values are set equal to or greater than the largest experimentally 
measurable value, which was cutoff=ln(50,000) for the Train-set. Accordingly, for these peptides 
the norm in (2) is set to be 
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cutoff  if cutoff
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S
S
S S
>− =  − <      (4) 
To avoid over-fitting, a second term is added to the minimization function in (2): 
{ }( ) { }( ) 2, , ,
,
,Ψ = Φ + ∑i a i a i a
i a
s s sλ λ
        (5) 
By minimizing with a non-zero λ value, a tradeoff is introduced between optimally reproducing 
the experimental IC50 values (including their inevitable experimental error) and minimizing 
parameters si,a. This forces all parameters si,a towards zero, which do not significantly lower the 
distance Φ. The optimal value for λ is determined by 10-fold cross-validation on the Train-set, 
i.e. splitting the total set of peptides into 10 subsets, establishing a scoring matrix using 9 of 
these subsets and making predictions with that matrix for the left out subset. Figure 5 depicts the 
sum of the distances between these predictions and the experimental values as a function of λ.  
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Figure 5: Cross validated distance as a function of λ  
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The optimal predictions were made with λopt=1. The resulting SMM scoring matrix is shown in 
Table 1. The lower a score, the better an amino acid is suited for binding at the given position.  
A similar mathematical concept is used to solve 'inverse problems', where λ is called the 
regularization parameter. A short introduction to inverse problems is given in (Press, et al., 
1992), chapter 18. To minimize equation (5), a commercial non-linear optimizer (Frontline 
Systems, 1999) using a generalized-reduced-gradient method is applied. 
Table 1: SMM scoring matrix for binding to HLA-A0201 
 Pos 1 Pos 2 Pos 3 Pos 4 Pos 5 Pos 6 Pos 7 Pos 8 Pos 9 
A 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
R 0.58 0.74 3.17 0.13 0.78 1.30 1.35 0.33 2.76 
D 4.90 0.74 1.46 -1.50 -0.15 -0.14 1.50 1.06 2.76 
N 1.47 0.74 2.03 -1.48 -0.36 -1.78 0.51 -0.76 2.76 
C 0.93 0.74 0.96 -0.96 -0.82 -1.15 0.56 0.57 2.76 
E 3.46 0.74 2.79 -1.24 0.40 -0.74 -0.17 0.39 2.76 
Q 1.63 0.74 1.24 -0.34 -0.41 -0.52 0.61 0.36 2.76 
G 0.50 0.74 1.08 -0.83 -0.64 -0.60 1.22 0.54 2.76 
H 1.33 0.74 0.90 -1.44 -0.39 -0.60 -0.43 0.06 2.76 
I 0.58 -0.42 1.54 1.67 -0.78 -1.40 -0.29 0.59 -0.50 
L 0.29 -3.06 -0.38 -0.17 -0.03 -1.48 -0.01 0.26 0.50 
K -0.20 0.74 2.25 0.22 0.05 1.43 1.73 1.20 2.76 
M -1.46 -2.72 -1.02 0.36 -0.41 -1.43 -1.08 0.58 0.91 
F -1.24 0.74 0.13 -0.45 -1.84 -1.48 -1.64 -1.10 2.76 
P 3.63 0.74 1.12 -0.67 0.93 -0.90 -1.60 -0.66 2.76 
S 0.24 0.74 1.05 -0.25 -0.26 -0.26 0.18 0.08 2.76 
T 0.82 0.17 1.70 -0.63 -0.75 -2.20 0.17 -0.00 1.06 
W 0.38 0.97 -0.03 -2.38 -1.49 -1.07 -1.67 0.02 2.76 
Y -1.91 0.74 -0.89 -0.12 -1.74 -1.37 -2.34 -0.77 2.76 
V -0.09 -0.31 1.28 1.15 -0.44 -2.13 0.03 1.04 -0.81 
 Offset 10.14        
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2.5 Evaluating prediction quality 
In this chapter, the predictions of diverse methods on equally diverse datasets have to be 
compared. To do this fairly, ROC curves are used (Bradley, 1997): For a given cut-off value 
which separates peptides by their predicted score into potential binders and non-binders, the two 
variables sensitivity (true positives / total positives) and 1-specificity (false positives / total 
negatives = false alarm rate) are calculated. By systematically varying the cut-off value from the 
lowest to the highest predicted score, a ROC curve like Figure 6 is plotted. Prediction quality is 
measured by the area under the curve (AUC), which is 0.5 for random predictions and 1.0 for 
perfect predictions. The AUC is equivalent to the probability that the score of a randomly chosen 
binder is higher than that of a randomly chosen non-binder. This measure has the advantage of 
not relying on a single arbitrarily chosen cut-off value for the prediction score, and can be 
equally applied to all datasets and prediction methods.  
2.5.1 Statistical significance for differences in AUC 
To assess if one prediction is significantly better than another, the set of peptides for which 
predictions are made was re-sampled. Using bootstrapping with replacement, 50 new datasets 
were generated with a constant ratio of positives to negatives. The difference in AUC for the two 
predictions on each new dataset is then calculated. One prediction is significantly better than 
another if the distribution of the differences in AUC values is significantly above zero, which is 
measured using a standard t-test with a p-value of 0.001. 
2.6 Comparison of matrix based predictions: SMM, PM, BIMAS and 
SYFPEITHI 
The four matrix based methods had to predict which of the peptides in the Blind-set are binders. 
The Blind-set is the only set truly ‘blind’ to all methods, i.e. none of peptides in this set were 
included in the training data of any of the prediction methods. Figure 6 depicts ROC curves for 
all predictions. It indicates that the performance ranks in the order of SMM>BIMAS>PM over 
almost the entire range. SYFPEITHI is the worst method for sensitivities above 0.42 and 
becomes the best for specificities above 0.97. This is due to the fact that SYFPEITHI predictions 
reflect other components of the antigen presentation pathway in addition to MHC-I binding, 
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leading to a decrease in sensitivity when predicting binding alone. The area under the ROC curve 
(AUC) gives a single number describing prediction accuracy of a method. Figure 6 translates to 
AUC values of 0.869 for SMM, 0.846 for BIMAS, 0.795 for PM and 0.745 for SYFPEITHI. The 
AUC values for the predictions of all methods on the other test sets (BIMAS-set and 
SYFPEITHI-set) are listed in Table 2. For both of these sets, SMM makes the best predictions of 
all truly blind methods.  
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Figure 6: ROC curve for matrix based prediction methods on the Blind-set.  
For each method, the cutoff was varied from the lowest to the highest predicted score 
of any peptide in the Blind-set. For each cutoff value, the sensitivity and specificity 
were calculated, and plotted in the graph.  
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Table 2: Comparison of prediction quality 
AUC on Test Set 
Prediction Method 
Independent 
Binding 
Assumption Blind SYFPEITHI BIMAS 
SMM, λ=1 Yes 0.869 0.848 0.866 
SMM, λ=0 Yes 0.856 0.846 0.865 
BIMAS Yes 0.846 0.829 (0.875) 
PM Yes 0.795 0.792 0.757 
SYFPEITHI Yes 0.745 (0.865) 0.754 
SMM + pair coef. No 0.873 0.852 0.869 
ANN No 0.796 0.788 0.762 
Additive method No 0.820 0.770 0.830 
CART No 0.708 0.620 0.539 
 
Two elements make the SMM approach different from other matrix based methods. First, it 
incorporates the experimental information of heavy non-binders precisely into the distance 
defined in equation (2). Since only the lower bound of the IC50 values for heavy non-binders can 
be determined, previous approaches have either left them out entirely or tried to fit them exactly 
to the lower bound. Second, the regularization technique was used. With errors in experimental 
measurements, there can be multiple sets of matrix coefficients that can reproduce the 
experimental data within their range of the error. Choosing the set of coefficients that gives the 
minimum distance may mean to overfit the problem. By incorporating a regularization 
parameters (λ in equation 5), a set of coefficients is chosen that reproduces the experimental 
results reasonably while keeping the parameter values small. This effectively prevents 
overfitting. Table 2 indicates that the AUC values at λopt=1, are better than those at λ=0 for all 
test sets.  
2.7 Comparison of general predictions: ANN, CART and the additive method 
Figure 7 shows ROC curves for general prediction methods (not making the independent binding 
assumption) on the Blind-set. The corresponding AUC values are also listed in Table 2. ANN 
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and the additive method make consistently better prediction than the CART tree. None of these 
previously published general methods reaches the prediction quality of SMM or BIMAS which 
made the independent binding assumption.  
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Figure 7: ROC curves for general prediction methods on the HLA-A2 Blind-set.  
The Figure contains ROC curves described in the legend of Figure 6. Since there are 
only three terminal nodes in the CART tree, corresponding to three different scores, 
its ROC curve consists of only two non-trivial points.  
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At first glance, this is surprising, as the general methods should be able to describe all binding 
mechanisms, including the simple case of independent binding. Why does the more restrictive 
matrix approach perform better? This can best be seen for the CART algorithm. As shown in 
Figure 8A, CART suggests to split node 3, but not node 2. If this exactly described reality, 
peptides in node 3 would bind differently than peptides in node 2, signifying an interaction 
between positions 2 and 1 only for peptides with an L or M at position 2. In contrast, if the 
independent binding assumption is true and there are no interactions between positions 2 and 1, 
the split described for node 3 should also be applicable to node 2. Testing this on the Blind-set 
(Figure 8B) shows that transferring the split actually works, as the new nodes resulting from the 
transferred split are more homogenous than node 2. The CART algorithm cannot identify this 
split, because it can only use the peptides in node 2 to decide about splits at node 2, and there are 
only 11 binders left in that node. This shows that general methods simply require more training 
data to achieve the prediction quality of matrix-based methods, if the independent binding 
assumption holds to a high degree. 
 In case of the additive method and the ANN, lack of data has lead to overfitting. The additive 
method has 1850 free parameters, the ANN architecture taken from (Gulukota, et al., 1997) more 
than 9000 neurons. This number of parameters cannot be determined reliably for the Train-set 
containing only 533 experimental data points. For the ANN, choosing a different architecture 
with less free parameters would probably have improved its prediction quality. For the additive 
method, the overfitting seems to effect mainly the interaction coefficients. When neglecting 
these coefficients which describe interactions between neighboring amino acids, and keeping 
only those compatible with the independent binding assumption, the prediction quality improves.  
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Figure 8: Classification tree for peptides binding to HLA-A0201 
Each ellipse denotes a node corresponding to a set of peptides, with the first number 
indicating the number of binders, and the second number indicating the total number 
of peptides in the node. The splits in the nodes are symbolized by arrows, which lead 
to daughter nodes. To the right of each node is a reference number (1-5) used in the 
text. (A) the optimal tree generated for the Train-set. (B) the tree in (A) is used to 
classify peptides in the Blind-set. The additional split on the lower left with dotted 
arrows, which is taken from the split of node 3 in (A), improves the classification. 
This indicates that the tree in (A) was not optimal.  
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2.8 Extending SMM with pair coefficients 
The results of the previous section show that given the limited data, general methods tend to 
perform worse than matrix based ones. In this section a general method that uses the matrix 
predictions as a starting point is developed. This is done by quantifying the contribution to 
binding of interactions of peptide positions with pair coefficients s'i,a,i',a'. For example, coefficient 
s'3A,7L (**A***L**) describes the difference in binding between the following two scenarios: (1) 
an Alanine is at the third AND a Lysine at the seventh position of the peptide and (2) the sum of 
the average contributions of having an Alanine at the third position, described by matrix value 
s3A (**A******), and having a Lysine at the seventh position, described by s7L (******L**). 
The total score for a given peptide k with the amino acids ak(i) at positions i is then given by  
( ) ( )
'
, , ', '
'
'
k kk k i a i i a i
i i
S S s= + ∑∑
         (6) 
where Sk is the matrix score defined in equation (1), and the sum includes all pairs of amino 
acids found in the peptide. For 9-mer peptides, this would result in 20*20*36 =14400 different 
pair coefficients. Since it is impossible to determine that many coefficients given the limited 
data, a two-stage selection process is applied: In the first step all coefficients for which fewer 
than Nmin=10 peptides exist in the Train-set are eliminated, as they lack sufficient experimental 
information. The optimal values for the remaining 269 pair coefficients can then be calculated by 
minimizing  
{ }( ) { }( ) 2, , ', ' , , ', ' , , ', '
, , ', '
' ' , ' ' ' ' 'i a i a i a i a i a i a
i a i a
s s sλ λΨ = Φ + ∑
     (7) 
where Φ' is the same as Φ in equation (2), except that scores S'k are used instead of Sk. When 
optimizing the pair coefficients s'i,a,i',a' in equation (7), the matrix coefficients si,a are frozen at 
their optimal value determined from equation (5).  
In a second selection step, the Train-set is split into 10 equal-size non-overlapping subsets and 
10 different optimal values for each pair coefficient are determined by leaving out one subset at a 
time and minimizing equation (7). If a pair coefficient contains both positive and negative 
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optimal values, it cannot be estimated reliably from the Train-set. Therefore, it is discarded. 
Setting all 145 discarded coefficients to zero, equation (7) is minimized to determine the values 
of the remaining 124 pair coefficients.  
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Figure 9: Using cross-validation to determine the optimal λ' 
The distance between the predictions of SMM + pair coefficient and the 
experimental IC50 values of the Train-set is plotted in comparison to the distance 
achieved with the SMM matrix alone. The improvement in prediction quality is 
highest for λ'opt = 5.  
The optimal value for λ' is again determined using cross-validation, similar to λ in equation (5). 
The cross validated distance as calculated using (2) compared to that of the plain matrix 
predictions is shown in Figure 9 for various values of λ'. For very high values of λ', the pair 
coefficients are forced to stay around zero, and the prediction accuracy is equal to that of the 
plain matrix approach. For λ' = 0, there is no restriction on the value of pair coefficients, leading 
to over-fitting, and the resulting performance is much worse than the plain matrix. In between, 
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there is a maximum in distance improvement at the optimal value λ'opt= 5. The values of the pair 
coefficients are listed in Table 3. 
Using the combined SMM matrix + pair coefficient method leads to an improvement in 
prediction quality over the plain SMM matrix on all test sets (Table 2). No other general method 
even reaches the SMM matrix predictions on one of the test sets. There are three main 
advantages of the novel matrix + pair coefficients approach: First of all, the pair coefficients are 
determined by systematic investigation of differences between the matrix predictions and the 
experimental values. As the matrix method is highly accurate, it is a better starting point than 
trying to determine both position contributions and position interactions all at once. Another 
novelty is that the interactions under investigations are limited to those with a sufficient amount 
of consistent training data. The third advantage is again the use of a regularization parameter (λ' 
in equation 7), which prevents the pair coefficients from overfitting the data. Its importance can 
be seen clearly in Figure 9: without it (λ'=0) the pair coefficients reduce prediction quality below 
that of the matrix alone. 
Table 3: Pair coefficient values  
Pos1 Pos2 value  Pos1 Pos2 value  Pos1 Pos2 value 
5 S 9 L -0.81  2 L 4 P -0.16  2 V 6 A 0.18 
2 V 5 A -0.52  4 E 9 L -0.15  8 P 9 L 0.19 
2 L 4 Q -0.43  2 L 8 L -0.14  7 N 9 V 0.20 
3 S 9 L -0.42  1 A 7 A -0.13  8 S 9 L 0.20 
8 H 9 L -0.41  1 A 9 V -0.13  2 L 5 E 0.20 
2 L 6 F -0.41  4 P 9 L -0.13  2 L 7 T 0.21 
6 A 9 V -0.39  2 L 7 P -0.12  4 S 9 V 0.21 
8 I 9 L -0.36  8 A 9 V -0.11  1 E 2 L 0.22 
2 L 3 A -0.36  5 A 9 V -0.11  5 I 9 L 0.22 
2 V 7 G -0.36  6 V 9 L -0.11  5 V 9 V 0.23 
1 G 2 L -0.34  4 A 9 V -0.10  3 A 7 A 0.24 
6 L 9 V -0.34  4 K 9 V -0.10  2 L 7 G 0.24 
2 L 4 C -0.33  6 S 9 L -0.09  6 Q 9 L 0.25 
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Pos1 Pos2 value  Pos1 Pos2 value  Pos1 Pos2 value
5 T 9 V -0.32  2 L 4 K -0.06  6 P 9 V 0.26 
2 L 6 Y -0.32  3 A 9 L -0.06  5 E 9 L 0.28 
1 A 2 L -0.31  1 A 6 A -0.06  2 L 3 S 0.28 
2 L 3 L -0.31  5 G 9 V -0.01  3 A 5 A 0.28 
2 L 5 I -0.31  5 A 7 A 0.03  2 L 4 G 0.29 
2 L 3 Y -0.29  5 A 8 A 0.04  2 V 3 R 0.30 
2 V 5 V -0.27  2 V 9 L 0.04  7 S 9 V 0.30 
2 L 4 S -0.26  3 V 9 V 0.07  5 Q 9 L 0.32 
4 K 9 L -0.26  2 L 6 H 0.09  2 L 7 A 0.33 
7 L 9 L -0.26  7 A 8 A 0.10  2 L 5 V 0.33 
6 P 9 L -0.25  5 L 9 A 0.10  2 V 3 G 0.34 
1 V 9 L -0.25  1 I 9 V 0.11  1 D 2 L 0.35 
2 L 6 V -0.25  2 L 5 R 0.12  6 T 9 L 0.35 
1 Q 9 L -0.25  4 K 5 A 0.13  3 L 9 V 0.38 
8 V 9 L -0.24  2 L 4 E 0.13  6 F 9 L 0.40 
2 L 7 S -0.24  2 L 6 G 0.13  4 L 9 V 0.40 
7 A 9 V -0.22  7 T 9 L 0.14  1 A 3 A 0.41 
7 P 9 L -0.22  3 A 6 A 0.14  1 P 2 L 0.41 
2 L 8 P -0.21  3 A 4 K 0.14  1 C 9 L 0.41 
1 L 9 V -0.21  2 V 4 S 0.15  2 L 6 L 0.41 
2 I 9 V -0.20  7 V 9 V 0.15  2 L 7 R 0.42 
6 A 7 A -0.20  1 D 9 L 0.15  2 L 5 S 0.46 
2 L 6 I -0.18  7 G 9 L 0.16  6 I 9 L 0.47 
8 G 9 L -0.18  1 L 9 L 0.16  6 L 7 L 0.52 
2 V 6 P -0.17  2 V 5 L 0.17  4 Q 9 L 0.56 
1 T 2 V -0.17  2 L 3 P 0.17  8 D 9 L 0.67 
7 A 9 L -0.17  2 L 8 G 0.18  5 S 9 V 0.74 
2 L 6 A -0.17  1 C 2 L 0.18       
2 L 4 T -0.17  1 A 8 A 0.18       
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Previously there was one published study comparing several methods to predict peptide binding 
to MHC-I (Yu, et al., 2002). There it was reported that the optimal choice of a prediction method 
depends on the number of peptides available for training: an ANN was outperformed by scoring 
matrices when the training data consisted of 234 peptides, while the ANN outperformed scoring 
matrices when trained on a set of over a thousand peptides. In principle this agrees with the 
results reported here.  
The new scoring matrix + pair coefficients approach should work over a large range of training 
set sizes. If little data is available, few or no pair coefficients will meet the criteria for inclusion, 
and the method is reduced to the SMM matrix. With more training data available, more pair 
coefficients are included, thus adjusting the complexity of the method to the available training 
data.  
2.9 Distribution of pair coefficient values 
Another advantage of the pair coefficients over methods like ANNs is that the extracted rules for 
binding are easy to interpret. The values determined for the pair coefficients provide direct 
information about the MHC-I-peptide binding mechanism. Since peptides bind in an extended 
conformation, one would expect the absolute values of the pair coefficients to be lower if their 
associated amino acid positions are farther apart. In Figure 10, two quantities that reflect the 
influence of position distance are plotted: the percentage of pair coefficients discarded due to 
conflicting information and the average absolute value of retained pair coefficients at the 
distance. Distances 6 and 7 have the highest percentages of discarded coefficients and distance 7 
has the lowest average value of retained coefficients, indicating weak or no interactions between 
positions at such distances. To a lesser extent, the levels of interaction at distances 2, 5, 6 and 8 
are also weaker than those at distances 1, 3 and 4. This agrees with the expected trend of stronger 
interactions for closer positions, but to a much lesser extend than expected. Also, this study does 
not confirm that (i, i+2) neighbors influence each other more strongly than (i, i+1) neighbors, 
which was expected because the side chains of next-neighbor amino acids face in the same 
direction thus allowing for direct interactions. Taken together, this shows that interactions are not 
limited to amino acids in direct contact, but can also play a role over longer distances, probably 
through the conformation of the peptide back-bone. 
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Figure 10: Distribution of pair coefficients. 
The percentage of discarded pair coefficients (top) and the average values of retained 
pair coefficients (bottom) are plotted against the distance between two interacting 
positions. 
While the presented results show that interactions between peptide positions do exist, the values 
of the pair coefficients are roughly an order of magnitude lower than the entries of the scoring 
matrix. This could be due to two reasons: the values for these coefficients are indeed small, or 
the noise level in the datasets is high – thus the coefficients are forced to low values by the 
regularization parameter λ'. Since the plain SMM performs very well, it can be believed that the 
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true values of the pair coefficients are indeed significantly lower than the values of the matrix 
entries. The low impact of pair interactions compared to the contributions of individual residues 
explains why methods making the independent binding assumption can make good predictions at 
all. 
2.10 Summary 
A novel sequence based algorithm was introduced that predicts the affinity of peptides to MHC-I 
molecules. Its basis is a matrix based prediction (SMM) where the entries describe the 
contributions of individual residues in a peptide to binding. Determining the matrix entries by 
minimizing the distance between predicted scores and measured IC50 values for a set of training 
peptides leads to significantly better predictions on three independent test sets than were 
obtained for a number of previously published methods. 
The SMM matrix was combined with pair-coefficients describing interactions between peptide 
positions, which further improve prediction quality. The pair-coefficient values for the first time 
quantify the influence of these interactions on peptide binding. Compared to the values of the 
matrix entries, they are rather small, which explains why good predictions are possible without 
taking peptide interactions into account at all. The distribution of the coefficient values also 
shows, that interactions in a peptide are not limited to residues in direct contact, but can also play 
a role over longer distances, probably through the conformation of the peptide backbone.  
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3 Peptide transport by TAP  
The TAP transporter is the main supplier of peptides binding to MHC-I molecules. As the TAP 
transport efficiency varies depending on the sequence of the transported peptide, the TAP 
preference influences the pool of peptides available for MHC-I binding. The importance of this 
influence in vivo is still subject to debate. Previous attempts to identify epitopes by an enhanced 
predicted TAP transport efficiency exhibited large allele specific differences. This has led to the 
conclusion that either MHC-I alleles are loaded by different degrees of TAP-independent 
transport (Brusic, et al., 1999), or that varying amounts of epitopes are transported as N-terminal 
prolonged precursors (Lauvau, et al., 1999). The second reasoning has been shown to be true for 
several epitopes (Goldberg, et al., 2002; Lauvau, et al., 1999) and receives further support by the 
identification of the protease ERA(A)P responsible for the N-terminal trimming of precursors in 
the ER (Saric, et al., 2002; Serwold, et al., 2002; York, et al., 2002). Motivated by this, a novel 
method to predict the effective transport of potential epitopes is developed in this chapter based 
on the predicted transportability of the epitopes themselves and their precursors. 
This chapter consists of the following sections: First, an overview of existing methods to predict 
TAP affinities is given, which can be considered equivalent to predictions of TAP transport 
(section 3.1). The prediction quality of these methods is compared with a new SMM type scoring 
matrix established on a set of 9-mer peptides (section 3.2). In section 3.3 these predictions are 
generalized to be applicable to peptides of any length. This is the basis of a scoring algorithm to 
discriminate between presented epitopes and random sequences by their TAP transportability 
(section 3.4). Finally, it is shown in section 3.5 that epitope identification with combined 
predictions of TAP transportability and MHC-I affinity give better results than predictions using 
MHC-I affinity alone.  
Most of the results presented in this chapter are taken from (Peters, et al., 2003). 
3.1 Published prediction methods of in vitro TAP affinity 
TAP transport rates can be determined experimentally using transport assays (Nijenhuis, et al., 
1996; Wang, et al., 1998) where the transported peptides are trapped in the ER (e. g. by 
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glycolysation). However, these assays measure transport as well as further degradation in the 
ER, export from the ER and other side effects (Uebel and Tampe, 1999). Another experimental 
possibility is the use of in vitro affinity assays (Gubler, et al., 1998; Uebel, et al., 1997), in which 
the affinity has been shown to correspond closely to the transport rate of TAP (Gubler, et al., 
1998). Affinity data is easier to measure and interpret, which allows to gather comparably large 
datasets, and is therefore the basis of this work. In the following, the correspondence of TAP 
transport and affinity is taken to be exact, which allows to equate predictions of TAP affinity 
with predictions of TAP transport.  
To characterize the preference of TAP for 9-meric peptides, two scoring matrices were derived 
directly from experiments: The 'Ala-matrix' was constructed by using the peptide 
AAASAAAAY as a reference, and measuring IC50 values for the peptides possessing an 
exchanged amino acid at one of the 9 sequence positions (Daniel, et al., 1997; Gubler, et al., 
1998). The 'Mix-matrix' was generated using libraries of 9-meric peptides X1X2...Y...X9, where 
Xi stands for a mixture of different amino acids and Y is a specific amino acid occupying a fixed 
sequence position (Uebel, et al., 1997). These libraries compete in binding with the totally 
randomized peptide library X1X2.....X9. Similar to the scoring matrices derived in chapter 2, the 
entries in these matrices can be summed up to predict the affinity of any 9-meric peptide.  
In (Daniel, et al., 1998), an ANN was trained on TAP binding data from a set of peptides. The 
ANN predictions were compared to those made by the Ala-matrix, and were shown to be slightly 
but significantly better.  
3.2 Comparison of affinity predictions for 9-mers 
The TAP affinity predictions of the two experimentally derived matrices described above were 
compared on a set of 430 peptides with measured IC50 values (Daniel, et al., 1998). The 
resulting scatter plots are depicted in Figure 11, showing that the Mix-matrix makes significantly 
better predictions than the Ala-matrix.  
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Figure 11: Comparison of predicted and measured in vitro TAP affinity values of 9-mer 
peptides  
The scatterplots depict the observed log(IC50) values of 430 9-meric peptides versus 
predicted log(IC50) values using the scoring matrix indicated at the bottom right of 
each panel. The solid curves represent linear regression lines.  
With the measured IC50 values of the 430 peptides, it is possible to establish an SMM matrix as 
described in section 2.4. To be able to compare the prediction quality of this method with that of 
the two matrices derived directly from experiments, five different SMM matrices were 
established each trained on a subset of the 430 peptides. For each of these 5 subsets, an optimal λ 
was determined by cross-validation as shown for one subset in Figure 12. Each of the five SMM 
matrices was then used to predict the IC50 values of the peptides not included in its training data. 
The resulting scatter plot is also depicted in Figure 11, which shows that the SMM matrix makes 
significantly better predictions than the Ala- or Mix-matrix.  
 
 40/112 
0
1000
2000
3000
0.1 1 10 100λ
Pr
ed
ic
tio
n 
di
st
an
ce
  
 
Figure 12: The Cross validated distance of measured and predicted TAP affinities is plotted as 
a function of λ 
The distance between SMM matrix predictions and measured IC50 values in five-
fold cross validation is plotted. The best predictions are made for λopt=5. 
By averaging over the three scoring matrices, the 'consensus-matrix' (Table 4) is generated, 
which is expected to give better predictions than the individual matrices because their errors can 
partially compensate each other. A scatter plot for its predictions is also shown in Figure 11. As 
expected, the consensus matrix gives the best results although the SMM-matrix is only 
marginally worse. The ANN predictions from (Daniel, et al., 1998) were not available for a 
direct comparison. However, as they were only slightly better than those of the Ala matrix, 
which makes the worst predictions of the three individual matrices, it can be assumed that the 
consensus matrix predictions are at least as good as those made by the ANN.  
 
 41/112 
Table 4: TAP consensus matrix 
 (N1)  Pos 1 
(N2)  
Pos 2 
(N3) 
Pos 3 
 
Pos 4 
 
Pos 5 
 
Pos 6 
 
Pos 7 
 
Pos 8 
(C) Pos 
9 
A -1.56 -0.25 -0.10 0.24 -0.10 0.17 0.27 -0.00 0.55 
C 0.05 -0.01 -0.02 0.11 0.09 0.05 0.00 -0.13 0.00 
D 1.37 1.42 1.83 -0.23 0.33 0.32 1.07 0.32 1.83 
E 1.65 0.02 1.51 0.08 0.54 -0.13 0.64 0.44 1.58 
F 1.03 -0.45 -1.05 -0.50 -0.26 0.08 -0.50 0.17 -2.52 
G 0.28 1.14 1.70 0.45 0.66 0.12 1.41 -0.38 1.41 
H 0.21 0.33 -0.23 -0.21 -0.11 -0.06 -0.19 0.39 0.55 
I -0.11 -0.49 -0.62 -0.09 -0.42 -0.75 -0.94 0.45 -0.52 
K -1.03 -0.41 0.09 -0.23 -0.08 -0.26 0.44 0.12 -0.45 
L -0.50 0.09 -0.11 0.11 -0.34 0.02 -0.73 0.01 -0.94 
M -0.38 -0.46 -0.58 -0.35 -0.26 0.30 -0.64 -0.11 -0.29 
N -1.43 0.69 1.01 0.38 0.49 -0.27 0.16 0.33 1.33 
P 1.43 3.00 0.22 -0.04 -0.72 -0.13 -0.84 0.03 -0.09 
Q 0.47 -0.97 0.39 0.15 0.15 -0.07 0.34 0.26 0.12 
R -1.34 -1.47 -0.42 -0.27 -0.32 -0.75 -0.09 -0.42 -1.47 
S -0.56 -0.34 0.11 0.27 0.45 0.31 0.87 -0.51 2.26 
T -0.12 -0.04 0.43 0.23 0.43 0.49 0.39 -0.46 0.72 
V -0.49 -0.50 -0.71 0.27 0.37 -0.02 -0.29 0.10 -0.30 
W 0.54 -0.64 -1.65 -0.18 -0.78 0.31 -0.50 -0.63 -0.87 
Y 0.50 -0.67 -1.80 -0.18 -0.13 0.28 -0.87 0.02 -2.91 
 
3.3 Predictions of TAP affinities for longer peptides  
It has been described in the literature that binding of peptides to TAP is mainly influenced by 
their C-terminal and three N-terminal residues (Daniel, et al., 1998; Uebel, et al., 1997; Uebel 
and Tampe, 1999; van Endert, et al., 1995). Motivated by this, a new scoring scheme to predict 
IC50 values of peptides with more than 9 residues is introduced, which neglects the influence of 
‘inner’ residues: TAP affinities of peptides with arbitrary length are calculated by scoring only 
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the C-terminus and the three N-terminal residues using the four corresponding columns of the 9-
mer matrix. Thus, for a peptide with the amino acid sequence N1, N2, N3, N4, …, C the TAP 
score t is given by 
1, 1 2, 2 3, 3 9,N N N Ct mat mat mat mat= + + +       (8) 
where mati,Xi denotes the score of residue X at sequence position i.  
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Figure 13: Comparison of predicted and measured in vitro TAP affinity values for peptides 
longer than 9 amino acids. 
The scatterplots depict the observed log(IC50) values of 64 peptides versus 
theoretical log(IC50) values predicted using the scoring matrix indicated at the 
bottom right of each panel. The length distribution of the peptides was as follows: 36 
10-mers, 18 11-mers, 6 12-mers, and one 13-, 15-, 16-, and 18-mer. The solid curves 
represent linear regression lines.  
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To test how well equation (8) predicts TAP affinities of peptides with more than 9 residues, it 
was applied to 64 peptides between 10 and 18 amino acids in length with measured affinities. As 
shown in Figure 13, the correlation between predicted and measured affinity values is lower than 
for the 9-mers, but still significant. The consensus matrix again provided higher correlation than 
all other matrices, so that it was used in all further applications. 
3.4 Using TAP transport predictions for the identification of epitopes  
To assess the selective role of TAP within the MHC-I presentation pathway, a test set of known 
naturally processed epitopes is needed. This is taken from the SYFPEITHI database 
(Rammensee, et al., 1999) and contains all known 9-meric epitopes that are presented naturally 
by any human MHC-I allele except those presented by HLA-A0201 (which are used later on), 
and for which the sequence of the source protein is available. MHC-I ligands, which are known 
to bind but which are not presented naturally are not included as well as epitopes derived from 
signal sequences. All other 9-mers contained in the protein sequences from which the epitopes 
originated are taken as random control peptides (=non-epitopes). In the following, this set of 203 
epitopes and more than 60,000 random 9-mers is referred to as the HLA-X dataset. 
To measure the prediction quality, again ROC curves and their integral (AUC) are used (section 
2.5). First, the complete 9-mer consensus matrix is used to predict the TAP affinities of all 9-
mers in the HLA-X dataset. These affinities are then used to separate epitopes from random 9-
mers, resulting in the ROC curve plotted in Figure 14, curve (a), which corresponds to an AUC 
value of 0.702, indicating a relevant but not very good prediction. 
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Figure 14: ROC curves for the HLA-X dataset.  
Curve (a) was constructed using the entire consensus-matrix on the HLA-X dataset 
yielding an AUC value of 0.702. For curve (b) scoring equation (10) was used with 
α=0.2 and L=10, giving AUC=0.791. The improvement is nearly completely in the 
high sensitivity region. The arrow indicates the point in curve (b) which corresponds 
to the sensitivity and specificity reached when choosing the cutoff=1, which is used 
later in the combined TAP and MHC-I predictions.  
The same analysis was repeated but now including potential epitope precursors carrying N-
terminal extensions. TAP affinities for N-terminal precursors of length 9, 10, ..., L were 
calculated for all epitopes and non-epitopes by means of equation (8). The TAP transport score 
of a potential 9-mer epitope is obtained by averaging over the TAP affinities of itself and its 
precursors up to a maximal length L: 
( )
9
9, 1, 1 2, 2 3, 3
9
1
8
1
8
L
L l
l
L
C N N N
l
t t precursor
L
mat mat mat mat
L
=
=
= −
= + + +−
∑
∑
      (9) 
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Note that all precursors contribute to the transport score with identical C-termini, while the N-
terminal contributions are varying. Increasing successively the maximal number L of allowed N-
terminal extensions and using the corresponding TAP transport scores to discriminate between 
epitopes and non-epitopes, the AUC values depicted in Figure 15, curve (a) are obtained. For 
L=9 (no N-terminal extension), equation (9) is equivalent to equation (8) and the AUC value 
amounts to 0.700, which is only marginally lower than the value 0.702 obtained when using the 
complete consensus matrix. This finding further justifies the usage of equation (8). 
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Figure 15: Prediction quality for the HLA-X dataset as a function of the maximal precursor 
length 
Plotted is the prediction quality measured by the AUC of the TAP transport score for 
different predictions: (a) equal weight for N- and C-terminus (equation 9) (b) C-
terminus score only (equation 10, α=0) (c) optimal prediction with down-weighted 
N-terminus (equation 10, α=0.2) 
The AUC values improve significantly with increasing maximal precursor length L. This was not 
expected for L greater than 18, as the TAP transport efficiency for peptides exceeding this length 
has been shown to drop of significantly (van Endert, et al., 1994). Evidently, increasing step by 
step the possible length L of epitope precursors, the statistical average across their N-terminal 
scores will converge against a stable limit value thus rendering the influence of N-terminal 
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scoring less and less important for the prediction of TAP affinities. Hence in the limit LÆ 
infinity, only the C-terminus will account for differences in the TAP scores of different potential 
epitopes. To see how close this limit is, the AUC values were calculated using the C-terminus for 
scoring only (Figure 15, curve b). Surprisingly, the AUC value of 0.782 is higher than all AUC 
values obtained before. This finding raises the question whether the rise in AUC values seen 
with increasing length L of precursors does really reflect the usage of longer precursors in 
antigen production, or whether the N-terminal scores are just adding noise to the prediction, 
which is smoothed out with increasing L. To check this, the TAP transport scores of the N-
terminal residues were weighted by a factor α: 
 
, 9, 1, 1 2, 2 3, 3
98
L
L C N N N
l
t mat mat mat mat
Lα
α
=
= + + +− ∑      (10) 
In Figure 15, curve (a) corresponds to α = 1 and curve (b) corresponds to α = 0. If the increase in 
AUC values obtained with precursors L>9 is only an artifact, one would expect the AUC for all 
values of L to grow monotonously when decreasing α from one to zero. If not, one would expect 
to find the optimal value of α somewhere between one and zero. The latter case is true: A 
maximum value of AUC was obtained for α=0.2 (curve(c) in Figure 15), which was significantly 
above the AUC value obtained when only scoring the C-terminus. Curve (b) in Figure 14 depicts 
the ROC obtained when choosing the optimal values L=10 (i.e. one N-terminal extension) and 
α=0.2. Hence, predicting TAP affinities of N-terminally extended epitope precursors by down-
weighting their N-terminal scores in comparison to their C-terminal scores significantly 
improves the discrimination between epitopes and non-epitopes. Possible explanations for the 
'down-weighting' of the N-terminus will be analyzed below. 
 To exclude that the improvement in predictions obtained when choosing α < 1 is a specific 
property of the HLA-X dataset, the same scoring procedure was applied to a completely 
independent set of mouse epitopes. This H2-X dataset was also extracted from the SYFPEITHI 
database following the same rules as those for the HLA-X dataset, but using mouse instead of 
human MHC-I alleles. Again it is tried to separate epitopes from random 9-mers using the 
predicted TAP transport efficiency (Figure 16), which is based on measurements of human TAP 
specificity. It has been shown that there are significant differences between the murine and 
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human TAP specificity (Momburg, et al., 1994), as human TAP translocates peptides with 
hydrophobic and basic C termini, whereas mouse TAP prefers only peptides with hydrophobic C 
termini. As expected, this results in generally lower AUC values than those for the HLA-X 
dataset. Nevertheless, qualitatively the three curves in Figure 16 (a)-(c) are related to each other 
in exactly the same way as those shown in Figure 15 for the HLA-X dataset: Using the scores for 
the N- and C-terminus with equal weights (α=1) for the prediction of TAP affinities results in a 
worse discrimination between epitopes and non-epitopes than neglecting the N-terminus 
completely (α=0). Again, a better prediction is achieved when the scores for the N-terminus are 
down-weighted with α=0.2. 
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Figure 16: Prediction quality for the H2-X dataset as a function of the maximal precursor 
lengths 
Plotted is the prediction quality measured by the AUC of the TAP transport score 
given in equation (10) for different predictions: (a) equal weight for N- and C-
terminus (α=1) (b) C-terminus score only (α=0) (c) better prediction with down-
weighted N-terminus (α =0.2) 
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3.4.1 TAP transport predictions for individual MHC-I alleles 
The calculations made in the previous section were repeated for individual MHC-I alleles that 
make up the HLA-X dataset to see how much the results vary. This analysis was restricted to 
those alleles for which at least 10 epitopes are present in the HLA-X dataset (Table 5). Epitopes 
presented by different allele subtypes were pooled in one set, for example the 'HLA-B27' set 
consists of epitopes listed in the SYFPEITHI database to be presented by HLA-B27 (unknown 
subtype) and the subtypes HLA-B2702, HLA-B2704 and HLA-B2705. While the binding 
preference of the allele subtypes can vary slightly, the datasets would otherwise be too small, 
especially as for many entries in the SYFPEITHI database the four digit code identifying the 
exact subtype is not given. The only exception is the HLA-A0201 set, for which only epitopes 
presented by this allele subtype are included. 
First, it was studied how well the epitopes of each individual allele can be identified by TAP 
affinity scores computed without inclusion of possible precursors or down-weighting of the N-
terminal residues (i.e. putting L=9 and α=1 in equation (10)). The resulting AUC values (Table 
5) show huge variations from 0.39 to 0.89. The differences in prediction quality for the 
individual alleles correspond very well with those reported in (Brusic, et al., 1999; Daniel, et al., 
1998), where the alleles HLA-B27, -A3 and -A24 were classified as efficient for TAP loading 
(high AUC) and the alleles HLA-B07, B08 and A0201 were classified as inefficient for TAP 
loading (low AUC).  
Repeating the AUC calculations with the optimal parameters L=10 and α=0.2 obtained for the 
entire HLA-X dataset, the AUC values fall in a much narrower range between 0.71 and 0.88, i.e. 
a subdivision into TAP-efficient and TAP-inefficient alleles is no longer preserved. These results 
provide evidence that TAP plays an equally important role for peptide loading of all alleles 
considered. Intriguingly, some alleles such as HLA-B27 or HLA-A3 seem to be preferentially 
loaded with peptides directly imported from the cytosol whereas other alleles such as HLA-B35 
or HLA-0201 are preferentially loaded with peptides entering the ER as N-terminally extended 
precursors where they are cut to final size. 
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Table 5: Individual alleles 
 # Epitopes 
AUC 
L=9, 
α=1 
AUC 
L=10, 
α=0.2 
Optimal 
α for 
L=10 
HLA-B35 10 0.39 0.80 0.0 
HLA-B07 11 0.43 0.71 0.0 
HLA-B08 10 0.69 0.80 0.0 
HLA-B44 11 0.78 0.88 0.0 
HLA-A24 37 0.81 0.87 1.0 
HLA-A3 11 0.82 0.75 1.2 
HLA-B27 20 0.89 0.77 4.0 
HLA-A0201 87 0.65 0.70 0.4 
 
Finally, the optimal value of α for each individual allele was calculated when setting L=10. The 
resulting values vary between 0 and 4, showing that the optimal value of α is extremely allele 
specific: The better the C-terminal residues required for effective TAP transport agree with those 
C-terminal residues enabling effective MHC-I binding to the given allele, the lower the weight 
that has to be put on the N-terminal residues. The optimal value of α=0.2 for the whole HLA-X 
dataset shows that, on the average, C-terminal amino acid motives required for effective TAP 
transport and MHC-I binding overlap stronger than the corresponding N-terminal motives. This 
is probably due to a stronger force for co-evolution on that motif, as the C-terminus undergoes 
no change from TAP transport to MHC-I binding, while the N-terminus can be trimmed. 
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3.4.2 Consequences of the uncertainty as to which N-terminally extended precursors 
are generated in vivo 
Another explanation why better epitope predictions were achieved with α < 1 is the uncertainty 
as to which epitope precursors are actually transported in vivo to liberate the definitive epitope in 
the ER by N-terminal trimming. Equation (10) is based on the unrealistic assumption that up to a 
critical length L all N-terminally prolonged precursors of an epitope are present in comparable 
abundance. Given that several precursor are not generated in vivo, their score for the N-terminus 
will ‘dilute’ that of the existent precursors. From the statistical point of view, this would favor to 
put a higher weight on the score of the C-terminus, or equivalently, to down-weight scores of the 
N-terminal residues.  
To estimate the implications of precursor uncertainty for the choice of α, simplified simulations 
of the MHC-I pathway were performed: Using the protein sequences from which the epitopes of 
the HLA-X dataset originate, a set of m fragments per sequence obeying a log-normal length 
distribution is generated, as was observed for the cleavage products of the proteasome (Kisselev, 
et al., 1999). These m fragments per sequence are considered to be the pool of potential epitope 
precursors generated by the proteasome that contain a C-terminal 9-mer which can bind to an 
MHC-I molecule. Which of these fragments becomes an epitope is decided by their affinity to 
TAP, which is calculated using equation (8). The fragment with the highest affinity per sequence 
is chosen, defining with its last 9 down-stream residues an epitope. The other m-1 fragments are 
discarded. It is then tried to identify these artificially generated 9-mer epitopes among all other 
9-mers contained in the protein sequences by applying the TAP transport score (equation 10) at 
varying values of α.  
The highest AUC values in all simulations were indeed obtained when choosing α<1. Figure 17 
shows the AUC values for such a simulated dataset. In this case the highest AUC value was 
obtained for L=11 and α=0.6. Varying the width of the hypothetical length distribution in the 
simulations, the optimal α values were always between 0.6 - 0.9, i.e. larger than the value α=0.2 
yielding the best prediction of epitopes on real experimental datasets but always smaller than 1. 
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Figure 17: Prediction quality on a simulated dataset 
Plotted is the prediction quality measured by the AUC of the TAP transport score 
given in equation 10 for different predictions: (a) equal weight for N- and C-terminus 
(α=1) (b) C-terminus score only (α=0) (c) optimal prediction with down-weighted N-
terminus (α=0.6) 
There are three free parameters in the simulation: the number m of different fragments used to 
define a single epitope and the mean and standard deviation of the log-normal length distribution 
of peptides generated. The larger the value of m, the higher the selective power that TAP has in 
the pathway in comparison to the proteasome and the MHC-I molecules. By systematically 
increasing the value of m, it was found that with m=10 the AUC value on the basis of the TAP 
score for the C-terminus alone was close to those AUC values in Figure 15 and Figure 16 
observed with real experimental data. The length dependence of the AUC values was in good 
concordance with that shown in Figure 15 and Figure 16 when choosing the mean of the log-
normal length distribution in the range 9 – 11.  
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3.5 Combining TAP transport predictions with predictions of MHC-I affinity 
It was tested whether the combination of predictions for two main steps of the presentation 
pathway, TAP transport and MHC-I binding, can improve the identification of epitopes. These 
calculations were performed on a set of 87 HLA-A0201 presented epitopes which had been 
omitted from the HLA-X dataset. For the prediction of peptide binding to HLA-A0201, the 
SMM scoring matrix developed in section 2.4 was used. On its own, this matrix already 
possesses a high capacity to identify the epitopes of the HLA-X dataset (AUC = 0.919, cf. Figure 
18 curve (a)).  
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Figure 18: ROC curves for the combined TAP and MHC-I prediction on the HLA-A0201 
dataset 
The black curve (a, AUC=0.919) shows the (very high) level of the MHC-I 
prediction alone. The consistently better gray curve (b, AUC=0.932) is made by 
classifying all 9mers with a TAP transport score worse than 1 as not transported 
(α=0.2, L=10), and limiting the MHC-I prediction to the transported peptides. 
To combine predictions of MHC-I binding with predictions of TAP transport, first the TAP 
transport efficiency is calculated for all 9-mers contained in the source sequences of the HLA-
A0201 epitopes using equation (10) with the parameters L=10 and α=0.2. All 9-mers with TAP 
scores above the threshold value 1 are classified as not transportable and excluded from the set 
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of epitope candidates. This cutoff value was chosen by examining the ROC curve for the HLA-X 
dataset: Only 1.5% of epitopes but 32% of random 9-mers have a higher (=worse) TAP score 
(arrow in Figure 14). In the second step, the predicted MHC-I binding scores of the remaining 
peptides (having TAP scores < 1) were used to discriminate between epitopes and non-epitopes. 
Based on this two-step prediction protocol, the AUC value increases significantly to 0.932 
(Figure 18, curve(b)). The improvement is largest in the high sensitivity region: Demanding 
100% sensitivity, specificity is increased from 52% to 62% when using the combined prediction 
instead of MHC-I affinity prediction alone.  
The same two-step prediction protocol was repeated for several mouse MHC-I alleles, using 
scoring matrices for the MHC-I affinity prediction that were measured by (Udaka, et al., 2000). 
Unfortunately, the number of epitopes available in the SYFPEITHI database per allele is small, 
ranging from 9 to 21 (Table 6). For three of the mouse alleles, the combined predictions gave 
better AUC values than MHC-I affinity predictions alone. For one allele (H2-Db), the combined 
prediction was worse. This shows that the combined MHC-I + TAP prediction using a human 
TAP matrix works for mouse epitopes, even though there are significant differences between the 
murine and human TAP specificity. This should improve significantly when using a scoring 
matrix based on experimental data for murine TAP.  
Table 6: Combined TAP and MHC-I predictions 
  AUC values 
Dataset # Epitopes MHC-I only MHC-I + TAP 
HLA-A201, 9-mers 87 0.919 0.932 
H2-Kb, 8-mers 21 0.961 0.965 
H2-Kb, 9-mers 9 0.855 0.879 
H2-Db, 9-mers 20 0.971 0.949 
H2-Ld, 9-mers 10 0.985 0.987 
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3.6 Confidence in the values of the free parameters α and L  
There are two free parameters in the prediction of TAP transport scores: α and L. Throughout 
most of this chapter, the values α=0.2 and L=10 were used, which were determined to be optimal 
for the HLA-X dataset containing epitopes from all human MHC-I alleles except HLA-A0201. 
These parameters show large variations when calculated for the individual alleles that make up 
the HLA-X dataset (Table 5), as they are heavily influenced by each individual alleles binding 
preference. The parameter values for the entire HLA-X dataset, which average out the individual 
alleles binding preferences, should reflect the true effect of TAP more accurately. The optimal 
parameter values calculated for the H2-X dataset (αopt=0.02 and Lopt=11), or the combined 
MHC-I and TAP predictions for HLA-A0201 (αopt=0.6 and Lopt=18), which should also reflect 
the true effect of TAP, are considerably different from those for the HLA-X set. However, the 
decrease in prediction quality when using α=0.2 and L=10 instead of the optimal parameters for 
these datasets is quite small (∆AUC < 0.006) compared to the loss in prediction quality of 
(∆AUC ~ 0.100) when making predictions without down-weighting and neglecting precursors 
(i.e. α=1, L=9). Apparently both parameters are meaningful, but their optimal values cannot be 
fixed within a narrow range. The usage of α=0.2 and L=10 can therefore be recommended, even 
though, from a biological perspective, L=10 seems to be too small as longer precursors are 
known to be used in vivo.  
3.7 Summary 
In this chapter, a novel method to predict the TAP affinity of peptides of any length was 
introduced, which gave reasonably good predictions for peptides 9 - 18 residues long. This was 
used to assign an effective TAP transport score to a potential epitope, by averaging over the 
predicted TAP affinities of the epitope itself and its precursors. The ability of this score to 
discriminate between random 9-mers and presented epitopes improved when down-weighting 
the influence of the N-terminal residues. This was reasoned to be the consequence of the 
uncertainty which epitope precursors are present in vivo as well as possible co-evolution in the 
preference for the peptide C-terminus of TAP and the average MHC-I molecule.  
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Using the predicted TAP transport efficiency to identify naturally processed epitopes for 
individual MHC-I alleles showed that TAP does exert significant pressure on the epitope 
selection of all MHC-I alleles. 
To combine TAP transport predictions with those of MHC-I affinity, all potential epitopes with a 
predicted TAP transport efficiency considered to be 'non-transportable' are eliminated. Using this 
as a filter prior to MHC-I affinity predictions improved the prediction quality considerably above 
that of the MHC-I affinity predictions alone. 
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4 Peptide generation by the proteasome 
The proteasome degrades intracellular proteins to peptides between 3-30 amino acids in length. 
This pool of peptides is thought to be the main source of MHC-I epitopes or their N-terminally 
prolonged precursors. As demonstrated in the previous chapter, identification of epitopes can be 
improved by using predicted TAP transport efficiencies as a filter that rules out poorly 
transported peptides without notably reducing the number of true epitopes. The obvious next step 
is to check if the same strategy can be applied to filter out those epitope candidates that are 
unlikely to be generated by the proteasome.  
This chapter starts with an evaluation of existing algorithms that predict proteasomal cleavage 
(section 4.1). Their predictions are poor, which is thought to be a consequence of the lesser 
quality of their training data, as proteasomal cleavage rates are inherently difficult to measure 
and interpret, which is discussed in section 4.2. To address this problem, a novel method to 
quantify proteasomal cleavage rates from time resolved experiments is introduced in section 4.3. 
This method is applied to a series of experiments analyzing the digestion of two polypeptide 
substrates by constitutive and immuno-type proteasomes (section 4.4). In the last section (4.5), 
the differences between digests with immuno- and constitutive proteasomes are discussed.  
Most of the results reported in this chapter are taken from (Peters, et al., 2002; Peters, et al., 
2003). 
4.1 Evaluating published algorithms predicting proteasomal cleavage 
Hitherto there are no indications that the C-terminus of proteasomal fragments undergoes further 
trimming along the MHC-I presentation pathway (Rock and Goldberg, 1999; Shastri, et al., 
2002). Therefore, selecting potential epitopes and their N-terminally prolonged precursors by the 
probability that their C-terminus is generated by the proteasome should single out false epitope 
candidates without loosing true epitope candidates. Currently, there exist three publicly available 
methods to predict proteasomal cleavage: NetChop (Kesmir, et al., 2002), PaProc (Nussbaum, et 
al., 2001) and FragPredict (Holzhutter, et al., 1999). All of these are trained on data from in vitro 
digests of proteins or oligopeptides.  
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4.1.1 NetChop 
The NetChop algorithm (Kesmir, et al., 2002) is an artificial neural network trained on different 
sets of experimental data. Here, the 20S version of NetChop trained on in vitro digest of yeast 
enolase (Toes, et al., 2001) and bovine β-casein (Emmerich, et al., 2000) was used. The output of 
the algorithm for each possible cleavage site within a protein sequence is a continuous number 
indicating the likelihood of cleavage. Predictions were obtained online at 
www.cbs.dtu.dk/services/NetChop.  
Alternative versions of NetChop are available that have been trained on collections of the 
flanking regions of known presented epitopes, which are thought to be cleavage sites of the 
proteasome. While this can be a valid approach, predictions trained this way can obviously not 
be used to evaluate the influence of the proteasome on epitope generation, as the proteasome is 
implied to be the source of all epitopes when using this kind of training data. Rather, the training 
data has to come directly from the proteasome itself, as is the case for proteasomal in-vitro 
digests. 
4.1.2 PaProc 
PaProc (Nussbaum, et al., 2001) is essentially a matrix based method combined with pair-
coefficients describing the interaction between the residues P1 and P1' surrounding the cleavage 
site. The coefficient values were determined using an evolutionary algorithm. The training data 
consists mainly of an in-vitro digest of yeast enolase plus several polypeptides (Kuttler, et al., 
2000). There are several implementations of the method based on different sets of experimental 
data. Here, the 'wild type III' method was used, which was trained on the largest dataset. PaProc 
is available online at www.paproc.de. Its output consists of 4 different discrete scores ('-', '+', '++' 
and '+++'), where '-' is designated to be 'non-cleavable'. 
4.1.3 FragPredict 
The FragPredict method (Holzhutter, et al., 1999) is not available online, but as a computer 
program distributed on request. It was the first published prediction method, trained on all in-
vitro digests of polypeptides published at that time. It is capable not only of predicting cleavage 
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sites, but also to predict which fragments are formed from combinations of cleavages. To be 
comparable to the other methods, only the cleavage site prediction algorithm was used.  
4.1.4 Identifying epitopes using proteasomal cleavage predictions 
For each peptide, the predictions of its C-terminal cleavage were used to determine if it has the 
potential to become an epitope or not. Figure 19 depicts the ROC curves for the three cleavage 
prediction methods when applied to the HLA-X dataset described in section 3.4. According to 
the AUC values, the best discriminations between epitopes and random peptides were achieved 
with NetChop (AUC=0.61), closely followed by FragPredict (AUC=0.59), while PaProc 
(AUC=0.54) was significantly inferior to the other two prediction methods. Comparing the ROC 
curves of Figure 19 with those of Figure 14, it can be inferred that the discriminating power of 
existing prediction methods for proteasomal cleavage sites is far below that of TAP transport 
scoring developed in the previous chapter, let alone those for MHC-I affinity.  
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Figure 19: ROC curves for proteasomal cleavage predictions 
For the three proteasomal cleavage prediction methods NetChop (AUC=0.61), 
FragPredict (AUC=0.59) and PaProc (AUC=0.54), the score for C-terminal cleavage 
is used to predict epitopes from the HLA-X dataset. 
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4.1.5 Combining proteasomal cleavage predictions with predictions of MHC-I 
affinity 
Next, combined predictions of C-terminal proteasomal cleavage and MHC-I binding were tested, 
using the same two-step prediction protocol as described for TAP in section 3.5. For each of the 
three prediction methods of proteasomal cleavages, a cutoff value singling out peptides as 'not-
generated' was chosen with a similar selective strength as the one used for TAP-transport, where 
30% of the peptides were classified as 'not-transportable'. For PaProc, the fraction of omitted 
peptides was necessarily larger, as this method predicted about 60% of peptide bonds to have the 
lowest score (‘-‘, not cleaved). The ROC curves for the combined predictions are shown in 
Figure 20; all of them indicating that the combined predictions are significantly worse than those 
based on predictions of MHC-I binding affinities alone.  
Apparently, the 2-step prediction protocol used successfully to combine TAP and MHC-I 
prediction fails when predictions of C-terminal proteasomal cleavages were used as a filter. This 
disappointing result may have three different reasons. One is, that the selective power of the 
proteasome is weak as it generates nearly every possible peptide. Second, there might be other 
proteases serving as suppliers of antigenic peptides besides the proteasome. Finally, existing 
prediction algorithms of proteasomal cleavage sites might not be accurate enough. The last 
explanation seems most likely, because in vitro digests of epitope-containing model substrates by 
the proteasome provide with very few exceptions the epitope or one N-terminally prolonged 
precursor (Kessler, et al., 2001). The poor quality of prediction algorithms for proteasomal 
cleavage sites is also evidenced by contradictory results obtained when applying them to the 
same set of test protein sequences. Most likely, the poor prediction quality of proteasomal 
cleavages is mainly caused by the lack of a sufficiently large set of quantitative and consistent 
experimental data on cleavage rates, which are more difficult to measure and interpret than the 
affinity assays used to characterize peptide binding to TAP and MHC-I. 
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Figure 20: ROC curves for proteasomal cleavage + MHC-I binding predictions 
Only peptides with a score for proteasomal cleavage of their C-Terminus better than 
a fixed cutoff are considered to be potential epitopes. They are assigned a score 
according to their predicted MHC-I binding affinity. The best results are obtained 
with NetChop (cutoff = 0.1, AUC=0.872) followed by FragPredict (cutoff = 0.5, 
AUC=0.858) and PaProc (cutoff = '+', AUC=0.623). All of these combined 
predictions are worse than using predicted MHC-I affinities alone (AUC = 0.919). 
4.2 Problems with evaluating experimental proteasome digests 
For an in vitro digest, proteasomes are incubated with a polypeptide or protein as a substrate. 
After a defined incubation time, the digest is stopped, and the generated mixture of peptide 
fragments is called the proteasomal digest of the substrate. To analyze these digests, usually 
Edman degradation or Mass Spectrometry (MS) are used. These methods are associated with 
different obstacles in the interpretation of results.  
4.2.1 A single snapshot of a digest does not provide reliable cleavage rates 
Using Edman degradation to analyze proteasomal digests, the peptide mixture is first separated 
using high performance liquid chromatography (HPLC). Ideally, each probe coming from the 
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HPLC should contain only one kind of peptide. The sequence and amount of each peptide can 
then be identified using Edman degradation. This is a reliable but time consuming method to 
produce quantified data, which has lead most experimentalists to limit the analysis of digests to a 
single incubation time, i.e. to analyze a snapshot of the fragment concentrations present in the 
digest at one time.  
A naïve way of interpreting this snapshot is to divide the concentration of each generated 
fragment by the amount of depleted substrate and interpret these ratios as relative generation 
rates. This is not a valid interpretation, because proteasomal digests do not follow a simple 
substrate + enzyme Æ substrate + product description. The proteasome can 're-process' its 
products, cutting them further into smaller fragments. While this re-processing may not play a 
significant role in vivo, where the products will either be degraded by other proteases or rescued 
from degradation by transport into the ER by TAP, it is unavoidable for in vitro experiments. 
Therefore, these relative generation rates would vary hugely depending on the incubation time, 
because longer fragments dominating at early times will later be cleaved into smaller fragments. 
This can also lead to misinterpretations of differences in the digests generated by different types 
of proteasomes. If two types differ only in their speed in which they degrade a substrate, the 
amounts of fragments generated can vary greatly after the same incubation time, even if their 
cleavage preference is completely identical (Figure 21) 
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Figure 21: Different proteasome species with identical cleavage preference can produce large 
differences in individual fragment amounts 
The data in the Figure stems from experiments described in section 4.4.1. The black 
and gray bars indicate the amount of nine pp89-25mer peptides produced by the T2 
and T2.27 proteasome after 2h of incubation. The peptide amounts were assessed 
from the respective MS-signals by using calibration curves. The position of each 
peptide fragment in the sequence of the substrate is indicated on the x-axis. There are 
significant differences in the amount of the peptides 5-15, 8-15 or 16-24. Since the 
cleavage probabilities are unaltered (values given in Table 8), these differences result 
exclusively from the faster procession by the T2.27 proteasome and its tendency to 
re-process shorter peptides.  
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Figure 22: Re-processing of peptides makes the relative amounts of fragments associated with 
each cleavage site time dependent 
The data used in this figure stems from the model fits described in 4.4.3, which are a 
noise-free set of peptide amount profiles. The four graphs depict the relative usage of 
the cleavage sites Y4, M6, Y7 and M24 in the pp89-25mer at various time points of the 
simulated digestion experiment with T2.27. The relative usage of a cleavage site at a 
given time point is calculated by summing up the amounts of all peptides beginning 
or ending at that cleavage site, divided by the maximum sum found for any site at 
that time point (always after L15 in these experiments). If the relative usage of a 
cleavage site was equivalent to the cleavage probability in the substrate, it should be 
constant over time, as the cleavage probability is an intrinsic property of the 
substrate. As can be seen from the graphs, the relative usage is not constant over 
time, as re-processing of a fragment increases the usage of weaker cleavage sites that 
are still present in the fragments of the substrate. 
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A much better way to evaluate proteasomal digests is to sum up the amounts of fragments 
associated with each cleavage site, thereby assigning cleavage strengths, which are thought to be 
equivalent to cleavage site usage in the original substrate. While this is much better than to look 
at individual fragments, this definition of cleavage strengths also depends on the digestion time, 
as shown in Figure 22. This is due to the following reasons: (1) As the strongest cleavage sites 
are cut first, their number decreases faster than others, making it more likely that weaker 
cleavage sites are used when fragments are re-processed. (2) It is known that shorter peptides are 
less likely to be cleaved then longer peptides, making the cleavage site usage dependent on its 
surrounding sequence, which changes when fragments are re-processed.  
4.2.2 MS-signals do not give quantified peptide amounts 
As discussed in the previous section, experiments evaluating only one digestion time-point can 
only provide a snap-shop of the digest that cannot completely determine the mechanism of 
degradation of the proteasome. Using Edman degradation to analyze the digests, repeating an 
experiment for several different digestion times means lots of work. A much quicker method to 
analyze digest data is mass spectrometry (MS). Here, the peptides of the digest are again 
typically separated by HPLC and thereafter analyzed by MS. While this allows for a highly 
sensitive qualitative analysis of the digest (a list of peptides that were generated in a detectable 
amount after a certain incubation time), estimation of the quantities of the peptides is 
problematic. The intensity of the MS-signal is in principal related to the detected peptide 
amount, but several intrinsic properties of the peptides influence their ionization behavior and 
therefore the MS-signal. The presence of aromatic amino acids (Valero, et al., 1998), phosphate 
groups (Janek, et al., 2001), and charged side chains (Cohen and Chait, 1996) such as guanidino 
group of arginine (Krause, et al., 1999) as well as the peptide size (Olumee, et al., 1995) have 
been reported to influence the signal intensity. Hitherto there is no reliable theoretical approach 
enabling the calculation of the MS-signal intensity from the sequence of a given peptide. In 
principle, the problem to derive amount values from MS-signals can reasonably well be solved 
by synthesizing the observed peptides and measuring calibration curves for each of them, but this 
is also a rather time consuming work, especially for digests of long protein substrates in which a 
large number of observed peptides is produced.  
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4.3 Novel protocol of experimental evaluation 
4.3.1 Determining peptide amounts from MS-signals 
In this section, a much more efficient method to assess peptide amounts from MS-signals than 
the use of calibration curves is proposed. The basic idea is to use mass balance rules: At an 
arbitrary time point of the digest experiment, the amounts of all peptides having at least one 
sequence position in common must add up to the amount of the substrate at the beginning of 
experiment. Mathematically, this conservation rule can be stated as 
( ){ }∈ =∑ i i 0i:j f a t a    (j=1,...,n)          (11)  
where a0 is the initial amount of the substrate of length n and ai(t) denotes the amount of peptide 
i at time t. The sum on the left-hand side of equation (11) includes all those peptides fi that 
contain sequence position j. From the calibration curves shown in Figure 26, it can be inferred 
that the relationship between MS-signal and peptide amount can be roughly approximated by a 
linear function, 
=i i ia v s            (12) 
where si denotes the MS-signal produced by peptide i and the signal conversion coefficient vi is a 
characteristic constant determined by the physico-chemical properties of peptide i converting its 
MS-signal into the respective amount value. Demanding fulfillment of equation (11) for all 
sequence positions, one may estimate the scaling factors vi by inserting relation (12) into the 
conservation equation (11):  
( ){ } α∈ = α∑ i i i 0i:j f v s t a     (j=1,...,n; =1,...,m)       (13) 
where the index α counts the number of discrete time points at which MS-signals for the peptides 
are available. Numerical values for the unknown conversion factors vi can then be estimated by 
minimizing the violation of the n x m conservation conditions (13). Violation of these 
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conservation rules may result from three sources: First, measurements of the MS-signals are 
subject to random as well as systematic errors. Second, the true functional relationship between 
the signals and the amount of a peptide will certainly deviate from a simple linear one. Third, the 
set of detectable peptides will never be complete. In particular, short peptides (1-3 residues) are 
likely to escape from HPLC-MS analysis. The latter fact gives rise to a systematic loss of mass 
as more small peptides are formed during the time-course of the digest. Therefore it is reasonable 
to determine the unknown conversion factors by minimizing the violation of the conditions (13) 
between two successive time points of the experiments, i.e.  
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and choosing the distance metric in (14) as 
2
2
x     if  x < 0
x
5 x   if x > 0
=            (15) 
which punishes the unlikely 'gain' of peptides (x > 0) five times higher than their more likely 
'loss' (x < 0). 
When minimizing the functional (14) with respect to the unknown signal conversion coefficients 
vi, one encounters the typical problem in regression analysis that the signal conversion 
coefficients of peptides with very small MS-signals are poorly determined because they can be 
largely varied without significant change of the functional Φ. Thus, to avoid unrealistic values of 
the calculated signal conversion coefficients, the minimization problem (14) is replaced by the 
constraint problem 
 MINIMUM!Φ + λ Ψ →         (16) 
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where the additional term 
 Ψ = ∑   
2
i
i 0
vlog
v            (17) 
measures the deviations of the vi's from a plausible reference value v0. This reference value v0 
was determined from a set of experimental calibration curves. Depending on the choice of the 
positive factor λ in (16), the minimization problem may become at the extreme either completely 
unconstraint (λ Æ 0), or all signal conversion coefficients are forced to the reference value v0 (λ 
Æ ∞ ). 
4.3.2 Kinetic modeling 
In this section, a kinetic model of the proteasome is introduced which is supposed to serve as a 
mechanistic platform for the interpretation and comparison of kinetic data produced by in vitro 
digestion of model substrates. Proteasomal degradation comprises a multitude of distinct 
elementary processes, such as uptake of the substrate, transport through the interior of the 
proteasome, binding to the active sites, threonine-catalysed cleavage of peptide bonds under 
putative formation of covalent acyl-intermediates, hydrolytic liberation of these acyl-
intermediates from the active-site threonine, and release of the products from the proteasome. As 
none of these elementary processes could be kinetically characterized so far, it makes no sense to 
incorporate them individually into a complex kinetic model containing a huge number of non-
identifiable parameters. Instead, a simple kinetic model is established by lumping all elementary 
processes involved in the complete procession of a peptide into a single overall processing step. 
Compared with classical enzyme kinetics, the resulting proteasome model can be considered as a 
sort of Michaelis-Menten model expressing the most essential kinetic features in terms of a few 
phenomenological parameters which can be identified from the experimental data. 
The time-dependent variation of the amount of peptides including the initial substrate is 
described by a system of linear kinetic equations, 
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Here kij is the rate constant with which peptide j is converted into peptide i per time unit and Ki 
is the total degradation rate of the i-th peptide. The peptides are labeled with decreasing lengths, 
a1 being the substrate, so that kij = 0 for i < j since cleavage always shortens a peptide.  
In order to derive an explicit expression for the transition rates kij, two cardinal terms are 
introduced: the procession rate rj of peptide j and the cleavage probability pk of a cleavable 
peptide bond (= cleavage site). These two terms are explained in the following. 
4.3.2.1 Procession rate 
The procession rate is the rate (i.e. number of events per time unit) with which a peptide 
undergoes a procession cycle. A single procession cycle encompasses all events taking place 
between uptake of a peptide into the proteasome and release of all peptides derived from it. For 
peptide j with length Lj, it is put 
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 +                 (19) 
where rmax represents the maximum possible procession rate, L0 represents a critical peptide 
length at which 50% of the maximum procession rate is reached, and the exponent c > 0 controls 
how sensitive the procession rate is to varying peptide lengths. This takes into account in a 
phenomenological manner that short peptides are degraded with lower turnover rates than longer 
peptides. A decelerated degradation with decreasing peptide length was observed for 
oligopeptides having up to 30 residues (Dolenc, et al., 1998), which is likely to be the maximum 
size of cleavage products. This type of length dependency can also explain why proteasomal 
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digests contain medium-size peptides which are not further degraded although they contain 
peptide-bonds which were cleavable in the original substrates. 
4.3.2.2 Cleavage probability 
A cleavage probability pk is assigned to all cleavage sites k of the protein substrate, i.e. to those 
peptide bonds which need to be cleavable to explain the peptide pattern observed in the digest. 
The cleavage probability of all other peptide bonds is a priori put to zero. The assumption is 
made that multiple cleavages may occur independently and randomly during a processing cycle. 
This implies that there are as many different partitions, i.e. possible subdivisons of a given 
peptide into smaller pieces, as there are different combinations of possible cleavages. If the 
substrate contains n* cleavage sites, there are 2n* such possible partitions, each of them occuring 
with a partition probability Pm (m=0,…,2n*-1 ) that is determined by the cleavage probabilities of 
the individual cleavage sites (cf. Figure 23 for a simple example with n*=2 ). 
 
Figure 23: Possible partitions of a peptide containing 2 cleavage sites 
Partition probabilities Pm are calculated by treating the individual cleavages as 
statistically independent events. For example: The probability P2 to fractionize the 
substrate according to partition 2 is given by the probability p2 for a cut to occur at 
cleavage site 2 times the probability (1-p1) that cleavage site 1 is not cut. 
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As this model generates all peptides that can be produced by any combination of cleavage sites, 
there will usually be more peptides predicted in the model than observed in the experiment. 
These peptides are called hypothetical peptides. 
4.3.2.3 Definition and estimation of rate constants 
The rate constants kij in the equation system (18) are chosen as the procession rate for peptide j 
times the sum of the probability of all partitions in which peptide i is generated:  
= ∑ij j m
m
k r 'P
           (20) 
Similarly, the coefficients Ki are given by  
>
= ∑i i m
m 0
K r P
           (21) 
where the sum includes all partitions except P0, in which no cleavage occurs at all. For a given 
set of cleavage probabilities and procession rate parameters, the kij and Ki have explicit values 
for which the linear differential equation system (18) can be solved analytically yielding explicit 
mathematical formulas for the theoretical peptide amount profiles ai(t). Thus, numerical values 
for the unknown model parameters (rmax, L0, c and pk with k=1, …, n*) can be determined by 
minimizing the distance between the theoretical peptide amount profiles and the observed ones. 
This minimization is performed using the following distance metric ∆:  
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             if 1     i.e.   a a ,a
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δ δ ≤ ∈   ∆ =  δ δ > ∉          (22)  
 72/112 
In (22) the symbols amid, amin and amax denote the mean, minimum and maximum peptide amount 
as derived from the measured MS-signal and asim denotes the simulated value predicted by the 
model. The distance metric ∆ increases steeply (as a quadratic function) for values of asim lying 
outside of the experimental range [amin, amax]. The weighting factor 5 is somewhat arbitrary as 
long as it is greater than 1. Subtracting 4 ensures continuity of the distance at δ=1. If a calibration 
curve was used to assess the amount of a peptide, the values for amid, amin and amax were taken 
directly from the calibration curve as described in Figure 26. If the mass balance method was 
used, the value for amid was determined using the signal conversion coefficient and putting 
amin=amid / 2 and amax= 2 amid.  
To be consistent with the experiment, the hypothetical peptides found only in the model should 
have amounts below the quantification threshold. As discussed below, this threshold is about 5 
pmol. To be on the safe side, the values amid = amin = 0 and amax = 2 pmol were chosen in the 
distance metric (22) for all hypothetical peptides. 
4.4 Application and testing of novel protocol 
4.4.1 Experimental setup 
Time-dependent peptide profiles were obtained from degradation of the two model peptides: 
pp89 (a 25-mer derived from the IE pp89 of the Murine Cytomegalovirus) and LLO, a 27-mer 
representing a partial sequence region of listeriolysin O from Listeria monocytogenes). These 
two substrates were digested by a constitutive proteasome (T2) isolated from T2 cells lacking the 
gene region for β1i and β5i and by an immunoproteasome (T2.27) isolated from T2 cells 
transfected with β1i and β5i and characterized by an enhanced incorporation of the endogenous 
β2i, the third immuno subunit. 
4.4.1.1 Peptide synthesis  
Peptides were synthesized by solid-phase methods on an automated Pioneer Peptide Synthesis 
System (PerSeptive Biosystems) using Fmoc chemistry. Peptide purity was confirmed by 
reversed-phase HPLC and MS. Syntheses were performed by Dr. P. Henklein (Charité, Berlin). 
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4.4.1.2 Purification and analysis of 20S proteasome complexes 
Proteasomes were purified from the human lymphoblastic cell line T2 and T2 cells transfected 
with the proteasomal subunits LMP2 and LMP7 (T2.27) as previously described (Kuckelkorn, et 
al., 1995).  
4.4.1.3 Peptide digestion assays.  
20 µg of the pp89-25mer or LLO-27mer oligopeptide and 3.3 µg of purified proteasomes were 
incubated in 1 mL of assay buffer (20 mM Hepes / pH 7.8, 2 mM Mg(CH3COO)2, 1mM 
dithiothreitol) at 37°C for 0, 0.5, 1, 1.5, 2, 3, 4, 6, 8 and 10 h, stopped by adding 0.1 vol 1% 
trifluoroacetic acid then frozen at -20°C. For each time point, two samples of 30 µL digest were 
used independently for HPLC-MS-analysis. The resulting MS signal intensities were averaged. 
The experiments were carried out in duplicate. 
4.4.1.4 HPLC-MS analysis 
Samples (proteasomal digests and dissolved peptides for the calibrations curves) were separated 
by reversed-phase chromatography on a µRPC C2/C18 SC 2.1/10 column (Pharmacia Biotech) 
by linear gradient elution (eluent A, 0.05% trifluoroacetic acid in water; eluent B, 0.045% 
trifluoracetic acid in 70% acetonitrile; flow rate, 73 µL/min). Analyses were performed online 
with an ion trap mass spectrometer (LCQ, Thermo-Finnigan) equipped with an electrospray ion 
source. As internal standard the peptide 9GPS (YPHFMPTNLGPS) was added to each sample. 
For calculation of the peak area the most intensive ion signal of the peptides was used. 
4.4.2 Comparing theoretical and experimentally derived fragment amounts 
4.4.2.1 Calibration curves 
For calibration of the peptide amount with the MS signal, dilution series were prepared from 
stock solutions of 12 individual peptides found in the pp89-25mer. The peptide amounts were 
varied in a broad range between 1 and 500 pmol. Three types of dilution series were analyzed: In 
a first series of experiments, MS-signals were recorded for each individual peptide under isolated 
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conditions, i.e. without presence of other peptides. In order to assess the impact of collective 
effects, the MS-signals for peptide mixtures were also recorded in two further dilution series 
experiments, one with equimolar mixtures of 12 peptides, the other one with different molar 
ratios for three groups of peptides (group A : group B : group C = 10 : 5 : 1, see the last column 
in Figure 24 for the group assignments).  
Peptide 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 group
 1-25 R L M Y D M Y P H F M P T N L G P S E K R V W M S  A
 1-24  B
 5-25  C
 5-22  -
 8-25  C
 1-15  A
 8-22  -
 4-15  -
 5-15  B
 16-25  A
 7-15  C
 16-24  B
 8-15  B
 16-22  -
 1-7  B
 5-10  -
 1-5  -
 11-15  -
 1-4  B
 12-15  -
 1-3  -
 23-25  
Figure 24: Fragments of the pp89-25-mer 
List of all fragments of the pp89-25mer detected in the proteasome digest. The 
second row contains the original 25-mer substrate, with those residues in bold print 
that are used as cleavage sites. For 12 peptides calibration curves were monitored, 
whereby the capital letter in the last column indicates the molar ratio with which the 
peptide was tested in a peptide mixture. 
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Peptide 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
 1-27 A Y I S S V A Y G R Q V Y L K L S T N S H S T K V K A
 1-16
 1-14
 1-12
 1-8
 1-6
 1-5
 1-3
 4-14
 4-12
 6-14
 6-12
 7-14
 9-16
 9-14
 13-27
 13-16
 15-27
 17-27
 17-26
 22-27  
Figure 25: Fragments of the LLO-27mer 
List of all fragments of the LLO-27mer detected in the proteasome digests. The 
second row contains the original substrate, with those residues in bold print that are 
used as cleavage sites.  
A typical calibration curve obtained in this series of experiments is depicted in Figure 26. The 
average relative deviations of the recorded signals from the mean are listed in Table 7 for the set 
of 12 peptides at the various amounts tested. The major source of these deviations are systematic 
differences between the calibration curves recorded either under isolated conditions or in peptide 
mixtures. Compared with these systematic deviations the variations of MS-signals between 
repeat measurements carried out under identical conditions are small.  
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amin amid amax
 
Figure 26: Calibration curve for the 11mer peptide 5-DMYPHFMPTNL-15 contained in the 
pp89-25mer.  
Three types of calibration curves were recorded, differing in the number and amount 
of peptides that were simultaneously present in one sample: z only the 5-15 peptide 
present, ¡ all 12 analyzed peptides simultaneously present at the same amount, S 
all 12 analyzed peptides simultaneously present but at different amounts. The solid 
lines interpolate linearly between the minimum, mean and maximum values 
recorded. In cases where the minimum or maximum recorded signal deviated from 
the mean by less than the average values given in Table 7, these average values were 
taken instead (see, for example, the minimum signal value at 500 pmol). The dotted 
lines indicate how a fixed MS-signal can be translated into an amount range. In this 
example, the MS-signal of 400 x 106 corresponds to a minimum amount of amin=140 
pmol, mean amount of amid=220 pmol and a maximum amount of amax=345 pmol. 
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Table 7: Amount dependent signal deviations monitored in the calibration curves  
Peptide 
Amount 
[pmol] 
median relative 
difference 
 max - mean 
median relative 
difference 
 min - mean 
500 20% -24% 
250 26% -40% 
125 38% -43% 
100 40% -43% 
50 73% -64% 
25 93% -66% 
10 104% -68% 
5 143% -80% 
1 176% -83% 
 
Increasing the peptide amount by about two orders of magnitude from 1 pmol to 500 pmol, the 
lower and upper boundary for signal variations around the mean value decrease by about one 
order of magnitude to a level of about 20%. For low peptide amounts, the relative signal 
variations are very large. While all peptides produced a quantifiable MS-signal when added at an 
amount of 10 pmol or higher, no quantifiable MS-signal was detected in 6 out of 72 experiments 
at a peptide amount of 5 pmol. Diminishing the peptide amount further down to 1pmol, the 
number of experiments with unsuccessful peptide recovery increases to 15 out of 72. It was 
concluded that - under these experimental conditions - peptide amounts below 5 pmol do not 
necessarily produce quantifiable MS-signals.  
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4.4.2.2 Assessment of peptide amounts from MS signals using the mass balance 
method 
For all peptides detected in the digests, time-dependent amount values were obtained from the 
measured MS-signals by applying the mass balance method described in section 4.3.1. Optimal 
values for the two control parameters λ and ν0 in (16) and (17) were determined in the following 
way: λ was continually increased starting with λ=0 until the maximum difference between the 
vi's was within a factor of 5. This yielded a value of λ=1 for the pp89-25mer digest and of λ=0.1 
for the LLO-27mer digest. ν0 was determined by taking the logarithmic mean of the experimental 
minimum and maximum values; this yielded ν0=1.  
Figure 27 shows the theoretically determined values of the signal conversion coefficients for the 
pp89-25mer digest in comparison to the experimental values assessed by means of calibration 
curves. Both methods are in good agreement: All calculated coefficients fall into the expected 
range, except for the peptide 1-4 which lies slightly above the experimental data.  
4.4.3 Fitting the kinetic model to the experimental data 
4.4.3.1 Comparison of experimental and theoretical time-dependent amount profiles 
For both substrates, the time-courses of MS-signals were translated into time-courses of peptide 
amounts using the signal conversion coefficients calculated by means of the mass balance 
method. Fitting of the kinetic model to the time-dependent amount profiles was performed as 
described in section 4.3.2. As the partition probabilities Pm decline rapidly with increasing 
number of cleavages, only partitions including up to four cleavages for the pp89 25-mer and up 
to six cleavages for LLO 27-mer were considered in the calculation of the transition rates kij and 
Ki (cf. equations 20 and 21) in order to save computation time.  
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Figure 27: Comparison of experimentally and theoretically determined signal conversion 
coefficients for fragments derived from the pp89-25mer 
Gray columns represent the signal conversion coefficients (cf. equation 12) obtained 
using the mass balance method. Black and white columns represent the experimental 
minimum and maximum for the coefficients. These boundaries were determined by 
picking the maximum signal of a given peptide measured in the time series of digest 
experiments and using the calibration curve to translate this signal into a minimum 
(amin) and maximum (amax) amount value (See arrows in Figure 26). Dividing the 
signal by amax and amin determines the experimental range for the value of the signal 
conversion coefficient.  
Figure 28 depicts measured and calculated time-dependent amount profiles for the pp89 25-mer 
substrate and the 9 peptides generated with the highest abundance. The expected range of the 
experimental values as defined by the boundaries amin and amax is indicated by the gray shaded 
area. For both types of proteasomes, the calculated amount profiles of almost all peptides fall 
into the range expected from the experiment. This also holds true for the other 12 peptides found 
in this experiment (not shown). The calculated amount of all 31 hypothetical peptides predicted 
by the model but not detected in the experiment was below 2 pmol, i.e. remained below the 
reliable experimental quantification threshold.  
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Figure 28: Time courses of peptide amounts for the pp89-25mer digests 
Connected boxes represent the theoretical amount values predicted by the model. 
The shaded areas indicate the amount ranges determined from the MS-signals in the 
proteasome digests using the mass balance method. The caption of each graph names 
the position of the peptide in the sequence of the 25mer substrate. The x-axis 
indicates the incubation time in hours, and the y-axis the amount in units of pmol. 
Note the different scaling of the amount axis for the various peptides.  
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A similarly good correspondence between experiment and model was obtained for the LLO-
27mer: Nearly all of the calculated time-dependent amount profiles for the 21 peptides detected 
in the digest (cf. Figure 25) were within the range of experimental uncertainty defined by the 
boundaries amin and amax, and the calculated maximal amount of all 26 hypothetical fragments 
was below the experimental quantification threshold of 2 pmol. For both substrates, the residuals 
between simulated and experimental time courses as measured by (22) are evenly spread across 
the entire time course, indicating random deviations between theoretical and experimental 
results.  
Since the number of adjustable model parameters is small (pp89-25mer: 13 parameters / LLO-
27mer: 12 parameters) compared with the number of data points (pp89-25mer: 220 
experimentally observed data points + 310 hypothetical data points / LLO-25mer: 210 
experimentally observed data points + 260 hypothetical data points), the good agreement 
between simulations and experimental data can be taken as a strong indication for the reliability 
of the model. 
4.4.3.2 Assessing the variability of model parameters with a jack-knife procedure 
To assess whether the numerical values for any model parameter differ significantly between the 
two types of proteasomes, it is necessary to relate the difference of the parameter values to their 
standard deviations. The standard deviation of a model parameter characterizes the expected 
range of its variability when determined from a set of independent repeat experiments. An 
alternative to carrying out new experiments is the so-called jack-knife procedure, which mimics 
the possible outcome of future experiments by replacing the original data base with a computer-
generated artificial dataset. Such a jack-knife procedure was applied by omitting the 
measurements at 4 consecutive time points from the original dataset. Repeating this procedure 
and fitting the kinetic model to each dataset yields a collection of parameter estimates from 
which standard deviations can be assessed. The estimated numerical values for the model 
parameters and their jack-knife standard deviations are listed in Table 8 and Table 9, and are 
graphically displayed in Figure 29 and Figure 30. Note that the cleavage probabilities obtained in 
different fits cannot be directly compared because the model can provide equally good fits with 
either a high maximal procession rate rmax combined with a low average level of the cleavage 
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probabilities pi or, alternatively, with low rmax and high pi. Hence, to make cleavage probabilities 
comparable, they have to be related to the probability P0 that no cleavage is made during 
procession of the substrate. The numerical estimates for the model parameters turn out to be 
fairly insensitive to large variations of the data base as produced in the jack-knife analysis. 
Table 8: Estimated model parameters for the pp89-25mer digests 
 T2 T2.27 
Parameter mean +/- mean +/- 
p3 / (1-P0) 0.019 0.006 0.003 0.002 
p4 / (1-P0) 0.054 0.007 0.053 0.006 
p5 / (1-P0) 0.001 0.001 0.002 0.000 
p6 / (1-P0) 0.015 0.007 0.004 0.003 
p7 / (1-P0) 0.163 0.019 0.105 0.041 
p10 / (1-P0) 0.004 0.004 0.003 0.001 
p11 / (1-P0) 0.012 0.004 0.006 0.002 
p15 / (1-P0) 0.622 0.041 0.710 0.062 
p22 / (1-P0) 0.027 0.006 0.009 0.003 
p24 / (1-P0) 0.220 0.026 0.349 0.079 
p0 = Π (1- pi) 0.65 0.07 0.43 0.13 
rmax 0.59 0.23 1.96 0.33 
L0 22.8 1.1 13.0 1.3 
c 11.0 3.0 11.1 9.5 
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Table 9: Estimated model parameters for the LLO-27mer digests 
 T2 T2.27 
Parameter mean +/- mean +/- 
p3 / (1-P0) 0.05 0.01 0.23 0.03 
p5 / (1-P0) 0.07 0.02 0.22 0.03 
p6 / (1-P0) 0.16 0.01 0.14 0.03 
p8 / (1-P0) 0.51 0.04 0.14 0.02 
p12 / (1-P0) 0.29 0.05 0.37 0.04 
p14 / (1-P0) 0.49 0.04 0.49 0.05 
p16 / (1-P0) 0.37 0.05 0.43 0.08 
p21 / (1-P0) 0.15 0.02 0.08 0.02 
p26 / (1-P0) 0.08 0.04 0.08 0.02 
p0 = Π (1- pi) 0.11 0.04 0.12 0.09 
rmax 0.07 0.01 0.22 0.04 
L0 17.1 2.5 12.6 0.0 
c 31.7 46.7 100.0 0.0 
 
Inspection of the graphs in Figure 29 and Figure 30 reveals that for both substrates tested, the 
immunoproteasome possesses a significantly higher procession rate combined with a greater 
preference to process shorter peptides compared with the constitutive proteasome. The effects on 
cleavage probabilities associated with switching from the constitutive proteasome to the 
immunoproteasome are diverse for the two substrates. For the pp89-25mer (Figure 29, Table 8), 
there are no significant changes of cleavage probabilities at all. For the LLO-27mer (Figure 30, 
Table 9), the result of this analysis is a significant change of the cleavage probability at 4 of the 9 
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detectable cleavage sites: an increase of cleavage probabilities at the residues I3 and S5 and a 
decrease at Y8 and H21. These results are discussed in more detail in section 4.5. 
 
Figure 29: Variability of model parameters for the pp89-25mer digests assessed by a jack-
knife procedure: Experimental peptide amounts determined by the mass balance method  
(a)-(b): Cleavage probabilities normalized to (1-P0). Each Figure shows the relative 
cleavage probabilities for 7 different fits: The black boxes indicate the cleavage 
probabilities obtained by fitting the model to the entire set of experimental data. The 
gray diamonds refer to parameter values obtained by fitting the model to reduced 
datasets where four 4 consecutive time points were left out from the experimental 
data. (c)-(d): The procession rate was calculated from the model parameters rmax, L 
and c according to equation (19) and then multiplied by (1-P0). Each Figure shows 
the results of 7 different fits detailed above.  
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Figure 30: Variability of model parameters for the LLO-27mer digests assessed by a jack-
knife procedure: Experimental peptide amounts determined by the mass balance method  
The amount of all relevant peptides identified in the digests of the LLO-27mer were 
derived from MS-signals by using the mass balance method. Variability of model 
parameters was assessed by repeated model fitting to truncated datasets (see legend 
of Figure 29). 
4.4.3.3 Checking the equivalence of model computations based on either the mass 
balance method or experimental calibration curves 
In a second series of computations, estimation of the model parameters for the pp89-25mer 
digests was performed on the basis of time-dependent amount profiles which have been 
constructed by using the available calibration curves instead of using the novel mass balance 
method for the 12 peptides indicated in the last column of Figure 24. Again, robustness of the 
numerical estimates was assessed by a jack-knife procedure as outlined above (Figure 31). 
Importantly, mean values and variances of all model parameters do not significantly deviate 
from previous values obtained by fitting the model to time-dependent amount profiles derived 
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from MS signals by the mass balance method. This result underlines the finding in Figure 27 that 
the mass balance method enables reliable conversions of MS-signals into peptide amounts. 
 
Figure 31: Variability of model parameters for the pp89-25mer digests assessed by a jack-
knife procedure: Experimental peptide amounts determined by using calibration curves  
Calibration curves were used to transform the MS-signals from the proteasome 
digests into peptide amounts, if available (see Figure 24). Using this dataset, the 
same seven fits as described in Figure 29 have been made to asses the variability of 
the model parameters. See the legend of Figure 29 for further details.  
4.4.3.4 Adequate fitting of data requires a length-dependent procession rate 
It was tested if a simpler version of the procession rate in equation 19 can produce similar quality 
time courses. To this end, constraints were imposed on the parameters L and c of the procession 
rate and the achieved quality of the fit was compared with the unconstrained one. The 
unconstrained fit yields a total residual distance of ∆=249 (∆=458) for the pp89-25mer (LLO-
27mer) digests according to the distance measure (22), when summed over both types of 
proteasome, all peptides and all time points. Setting L0=0, i.e. neglecting the length-dependence 
by equating the procession rate to rmax for all peptides, the total residual distance amounts to 
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∆=427 (∆=605), i.e. the quality of the fit decreases significantly. At the other extreme, setting 
L0= (substrate length-0.5) and c=1000 such that only the initial substrate undergoes procession 
with rate rmax while re-processing of proteolytic fragments is prevented, the total residual 
distance amounts to ∆=456 (∆=549) again indicating a clear drop in fit quality. These findings 
demonstrate that length restrictions in the procession of shorter peptides are an essential feature 
of proteasomal cleavage. 
4.5 Differences between constitutive- and immuno-proteasomal digests 
Comparing the model parameters determined for the digests by T2.2 and T2.27 proteasomes 
gives information about differences between them. First of all, both types of proteasome have a 
remarkably similar cleavage pattern. For the pp89-25mer, there is no significant difference in the 
determined cleavage probabilities at any cleavage site. This is an unexpected finding considering 
the large differences between the time-dependent product patterns produced by the two 
proteasome species. However, the theoretical analysis of the data demonstrates that these 
differences can be well accounted for by changes in the overall procession rate: Compared with 
the constitutive proteasome, the immunoproteasome works faster and accepts shorter peptides 
for re-procession. Since the kinetic model does not explicitly relate the procession rate to the 
various elementary steps involved in a procession cycle, it cannot be decided whether the higher 
procession rate of the immunoproteasome is due to an accelerated uptake and release of peptides 
or/and to a general increase in the catalytic capacity of its active sites. The finding that the 
immunoproteasome possesses a higher turnover rate than its constitutive counterpart is in 
agreement with previous observations (Boes, et al., 1994; Cardozo and Kohanski, 1998; 
Kuckelkorn, et al., 1995).  
Using the substrate LLO-27mer, the differences in the overall procession rate of the constitutive 
proteasome and the immunoproteasome are very similar to those obtained for the pp89-25mer. In 
addition, there are significant alterations of the cleavage probabilities at four cleavage sites 
which in a concerted fashion give rise to an enhanced production of the epitope 
(VAYGRQVYL) by the immunoproteasome.  
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In summary, the results obtained with two different oligomeric substrates show that the kinetic 
effects associated with replacement of the constitutive proteasome by the immunoproteasome 
can be subdivided into a non-specific enhancement of the overall procession rate and peptide-
bond specific alterations of cleavage probabilities. Since the latter effects are clearly restricted to 
a few cleavage sites it seems not very likely that the exchange of the active-site subunits by their 
interferon-inducible counterparts leads to a general stimulation of the trypsin-like and 
chymotrypsin-like activities accompanied by a depression of the peptidylglutamyl-peptide-
hydrolyzing activity as postulated in several previous studies (Aki, et al., 1994; Boes, et al., 
1994; Cardozo and Kohanski, 1998; Gaczynska, et al., 1996; Gaczynska, et al., 1993; 
Kuckelkorn, et al., 1995; Toes, et al., 2001). In particular, lacking changes of the cleavage 
probabilities at the three leucine residues present in the two substrates tested is hardly compatible 
with the common view (Groettrup, et al., 2001) that the immunoproteasome possesses a 
generally increased inclination for cleavages after certain categories of P1 residues 
(hydrophobic, branched chain, positively charged).  
Recently Toes et al. (Toes, et al., 2001) have compared the fragment patterns of denaturated 
enolase-1 (436 amino acids) generated by constitutive and immunoproteasome. Only about 25% 
of the peptides produced by the immunoproteasome were also found in constitutive proteasome 
digests. Such a diversity in the peptide pools generated by either proteasomes was not seen here. 
For both oligomeric substrates, the two peptide pools detected in the digest were identical for 
both types of proteasome. The various peptides differed only in their amount which to a large 
extend could be explained by differences in the overall procession rate. The obvious 
inconsistence of the results reported here with those of Toes et al. is remarkable and may have 
two reasons. First, it is conceivable that the mechanisms by which the 20S proteasome degrades 
a denaturated long protein substrate and a relatively short (25 or 27 residues long) oligopeptide 
differ in that threading of a 436 long peptide chain through the proteasome may pose additional 
constraints on the accessibility of the active sites. Second, a moderate (2-5 fold) variation of 
cleavage probabilities as found for some cleavage sites of the LLO-27mer may amplify to larger 
variations (4 - 25 fold) of respective peptide amounts. Given that the abundance of a 
considerable portion of peptides derived from a long substrate is close to the detection threshold, 
such variations in peptide amounts could result in an apparent 'loss' or 'appearance' of peptides. 
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It has to be emphasized that the model in its present form was established to describe the 
degradation kinetics of oligopeptides as typically used in in vitro digests. Extension of this 
approach to kinetic experiments with long substrates will certainly require modifications of some 
basic assumptions, e.g. concerning the monotonous increase of the procession rate with peptide 
size or the statistical independence of cleavage combinations.  
4.6 Summary 
Existing algorithms describing protein degradation by the proteasome deliver poor results when 
used to identify epitopes by their predicted C-terminal cleavage. This is believed to be the 
consequence of the lesser quality of experimental data available for training of these prediction 
algorithms. To tackle this problem, a novel protocol to interpret proteasomal digests was 
developed. This protocol addresses two problems: (1) How to quantify the amounts of peptides 
present in a digest when only MS data is available, and (2) how to extract cleavage rates from a 
digest in which fragments are re-processed.  
The conversion of MS-signals into peptide amounts is realized using mass balance equations and 
assuming a linear correlation between peptide amounts and their MS-signals. The amounts 
calculated with this approach are in good agreement with those determined using calibration 
curves. Problem (2) is addressed by developing a kinetic model of proteasomal digests. By 
fitting this model to the amount profiles from experimental digests, numerical values for 
cleavage rates are obtained, which are free parameters of the model. Comparing these fitted 
model parameters for digests made by constitutive and immuno-proteasomes shows that the 
differences in observed peptide amounts profiles can to a large extend be explained by an 
enhanced procession speed of the immuno-proteasome. 
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5 Summary of main results and conclusions 
In the last chapters, the three main agents in the MHC-I pathway were examined with the goal to 
develop tools to predict their function in the antigen processing pathway. For peptide binding to 
MHC-I, a new prediction algorithm was developed. It combines a matrix-based method (SMM), 
which describes the contributions of individual residues to binding, with pair coefficients, which 
describe pair-wise interactions between positions in a peptide. This approach outperformed 
several previously published prediction methods, and for the first time quantified the impact of 
interactions in a peptide. The superiority of this approach is believed to be the consequence of 
three main novel features: (1) the use of a regularization parameter, which prevents the pair 
coefficients and the matrix entries from overfitting the data. (2) the pair coefficients are 
determined by systematic investigation of differences between the matrix predictions and the 
experimental values. As the matrix method is already highly accurate on its own, this is a better 
starting point than trying to determine both position contributions and position interactions all at 
once. (3) the interactions under investigations are limited to those with a sufficient amount of 
consistent training data.  
The distribution of the pair coefficient values showed that interactions between adjacent peptide 
positions are somewhat stronger than those farther apart. However, this trend was seen to a much 
lesser extend than expected, signifying that interactions are not limited to neighboring amino 
acids in direct contact, but can also play a role over longer distances, probably through the 
conformation of the peptide back-bone. Compared to the SMM matrix entries, the pair-
coefficients are rather small. This explains why methods completely ignoring interactions can 
still make good predictions. 
Peptide affinities to TAP are considered to be closely related to their transport efficiencies. 
Therefore, the SMM matrix description developed to analyze peptide binding to MHC-I could 
also be applied to predict affinities of a set of 9-meric peptides to TAP. The SMM predictions 
were significantly better than those of two scoring matrices determined directly from 
experiments. Pair coefficients were not introduced here, to allow for the combination of all 
matrices into a single consensus matrix, which made the best overall predictions.  
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Using the experimental knowledge, that binding of a peptide to TAP involves mainly its C-
terminus and three N-terminal residues, a 9-mer scoring matrix can be employed to predict the 
affinities of peptides of any length by taking only these residues into account. This was 
demonstrated to give good predictions of TAP affinities for peptides of size 10 to 18. Being able 
to predict TAP affinities of peptides longer than 9 amino acids (the typical epitope length) is 
important because it has become clear that several MHC-I epitopes are generated by N-terminal 
trimming of precursor peptides that are likely to be transported into the ER by TAP. As the true 
in vivo precursors of an epitope are not known, a generalized TAP score was established which 
averages across the scores of all precursors up to a certain length.  
The highest prediction quality with this TAP score was achieved when the contribution of the N-
terminal residues were down-weighted. It was reasoned on the basis of simulations and of results 
from scoring for individual MHC-I alleles, that this down-weighting partially reflects co-
evolution of TAP and the average MHC-I allele as to the preference for certain C-terminal 
residues, as well as the uncertainty which epitope precursors are present in vivo. With this 
scoring method, the influence of TAP was found to be a consistent, strong pressure on the 
selection of MHC-I epitopes for all alleles. Using predicted TAP transport efficiencies as a filter 
prior to prediction of MHC-I binding affinities, it was possible to further improve the already 
very high classification accuracy achieved using MHC-I affinity predictions alone.  
Such a two-step prediction protocol failed when predictions of C-terminal proteasomal cleavages 
were used as the filter, i.e. relying on MHC-I affinity predictions alone gave better results than 
combining them with proteasomal cleavage predictions. This disappointing result is thought to 
be caused by the lack of a sufficiently large set of quantitative and consistent experimental data 
on cleavage rates, which are more difficult to measure and interpret than the affinity assays used 
to characterize peptide binding to TAP and MHC-I. Therefore, in the last chapter a new protocol 
for the evaluation of proteasomal digests was developed, which was applied to a series of 
experiments. The first problem addressed in this protocol is the quantification of data from MS 
experiments. As the signal strength detected for a peptide depends not only on its amount but 
also on its chemical properties, additional information is needed to quantify a signal, which 
usually requires extra measurements in the form of calibration curves. To avoid these additional 
measurements, a novel method based on mass-balance equations was introduced which demands 
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that the total amount of peptides having one sequence position in common has to be conserved 
throughout the digest. This allowed for reasonable estimations of the peptide amounts from MS-
signals in a digest. 
Based on this quantified data, the first kinetic model of the 20S proteasome was developed 
which is capable of providing a satisfactory quantitative description of the whole time course of 
product formation measured in an in vitro digest. As known from conventional enzyme kinetics, 
the minimum ingredients to establish an enzyme-kinetic model are (1) the maximum activity 
characterizing the catalytic step of the enzyme under ideal working conditions (e.g. substrate 
saturation) and (2) the affinity characterizing the strength of interaction between enzyme and 
substrate. These two essential parameters have been incorporated into the proteasome model in 
terms of the parameters processing rate and peptide-bond cleavage probability. The crucial 
advantage of this model-based approach consists in the possibility of differentiating between 
non-specific changes of the procession rate and peptide-bond specific kinetic effects. Changes of 
the procession rate alone may lead to an increase or decrease in the amount of a specific peptide 
only if re-processing takes place - a typical situation under in vitro conditions. In vivo, re-
processing of fragments is unlikely in view of the enormous amount of peptidase activity present 
in the cytosol. In this case, changes of the procession rate alone would result in a uniform 
increase or decrease of all fragments without affecting the relative proportions between them. 
Hence, a preponderance or repression of specific peptides (e.g. epitopes) over others can only be 
achieved by changes of the cleavage probability. 
The analyzed proteasomal digests provide evidence that immuno-proteasomes have a 
consistently higher procession speed than the constitutive-proteasomes. The cleavage patterns for 
both types of proteasomes are rather similar: All cleavage sites are found to be used by both 
types of proteasome, and only a minority show significant changes in their probability of usage. 
However, the analysis of just two rather short model substrates does not allow for the 
generalization of these results. Also, many more substrates will have to be analyzed to have a 
sufficiently large training base to establish a new prediction algorithm of proteasomal cleavage. 
Characterizing each element in the MHC-I pathway and combining predictions of their function 
is not the only possible approach towards a sequence based prediction of epitopes. It is also 
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possible to identify sequence motifs common to all epitopes presented by a specific MHC-I 
allele, as realized in the SYFPEITHI database (Rammensee, et al., 1999), and use this 
information for prediction. This approach does not differentiate between the influences of the 
proteasome, TAP or MHC-I on epitope selection, but has been shown to work well in practice. 
However, it has a principal drawback, as epitope sequences do not contain the full information 
used in the presentation pathway: The epitope may originate from a group of N-terminal 
prolonged precursors, generated by the proteasome, partially trimmed by cytosolic peptidases, 
transported by TAP into the ER and then cut to final size. These steps preceding binding to the 
MHC-I receptor will depend on sequence motifs in the flanking regions up- and downstream of 
the epitope, which are neglected when considering only the epitope sequences themselves. 
Hence, developing prediction algorithms for each individual step of the MHC-I presentation 
pathway and combining them should in principal be the superior approach. However, high 
quality experimental data for each step and advanced prediction techniques are needed to rival 
the prediction quality currently achieved by SYFPEITHI. Unfortunately, the predictive quality of 
the two approaches cannot be compared here, as there is no independent blind set available. 
SYFPEITHI is trained on the data used as test sets for the combined predictions developed in 
this work. For a neutral comparison, a significantly large set of newly identified naturally 
presented epitopes would be needed, or an older version of the SYFPEITHI prediction algorithm 
would have to be used and tested on more recently included epitopes. As a consequence, no 
conclusions about which method is currently better at identifying epitopes can be drawn here.  
When applying an epitope prediction protocol that is based on algorithms for several individual 
steps of the MHC-I presentation pathway, it is of utmost importance that each prediction 
algorithm is trained on data containing only information on that specific step. For example, 
prediction methods that are supposed to predict MHC-I binding, but have been trained on data 
including epitope presentation, implicitly predict the effects of TAP and the proteasome. A 
combination of such an 'impure' MHC-I binding prediction with a prediction of TAP transport or 
proteasomal cleavage thus bears the risk of overestimating the role of TAP or the proteasome in 
the presentation pathway  
The improvements achieved when including TAP transport of precursors into epitope predictions 
are in the high sensitivity regime of the ROC curve (cf. Figure 14). It is often argued that high 
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sensitivity of epitope predictions is of less practical relevance than having high specificity, i.e. to 
end up with a short list of high probability epitope candidates for a given protein sequence is all 
important. This view is wrong for two reasons: First, from the medical point of view, it can be 
equally interesting to identify all possible epitopes within a given protein sequence, requiring 
high sensitivity of the predictions. Secondly, when combining predictions for several steps of the 
MHC-I pathway whereby predictions of one step are used as a filter for the input to the next, it is 
very important to throw out as few true epitopes in each step as possible. Such a multi-step 
prediction protocol automatically increases specificity from one step to the next.  
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6 Outlook 
Summarizing the attempts in this work to improve epitope identification by combining different 
prediction steps, it has to be concluded that currently the only reliable strategy is to filter out 
those peptides exhibiting poor TAP transport scores, and use MHC-I binding affinity predictions 
to identify epitopes among the transportable peptides. This algorithm is implemented on the 
publicly available website www.mhc-pathway.net The website currently contains binding 
predictions for five different MHC-I alleles, which will be updated as more data becomes 
available. It is also planned to include more TAP scoring matrices describing its transport 
preference in different species.  
The next step along this line is to include the proteasome, for which currently no prediction 
algorithms with sufficiently high reliability are available. Accurate prediction of proteasomal 
fragments would lead to a further improvement of TAP transport predictions which then - 
instead of considering all precursors up to length L as equally probable - can be restricted to 
those precursors actually generated. Eventually, this should also make the down-weighting of N-
terminal residues in the TAP predictions obsolete, because there would be no uncertainty as to 
which precursors are generated, and co-evolution between peptide specificities of the 
proteasome, TAP and MHC-I would be included in the model. To establish a consistent database 
for proteasomal cleavage prediction, it is planned to apply the described novel evaluation 
protocol to a series of proteasomal digests with a large number of substrates and different types 
of proteasomes (e.g. constitutive / immuno proteasome, with and without the 11S and 19S 
regulators). The extracted cleavage probabilities can then be analyzed using the SMM 
framework established here for sequence based prediction of peptide affinities to MHC-I and 
TAP. 
In principal, the SMM + pair coefficients algorithm can be applied to all problems that require 
the prediction of a property associated with a sequence. However, the approach is likely to be 
successful only when the assumption of independent additive contributions of each sequence 
positions to the property under investigation is a decent approximation. To test the SMM + pair 
coefficient approach on problems completely different from affinity experiments, it was applied 
to the identification of cis-prolines from their sequence environment (Lorenzen, et al.) and the 
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prediction of contacts between residues of membrane helices and either residues of other helices 
or lipids in the membrane itself (Hildebrand, et al.), both with positive preliminary results. The 
application, refinement and testing of the limits of this approach is another goal for the future. 
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